<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7198842</article-id><article-id pub-id-type="doi">10.3389/fimmu.2020.00695</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Disease Resolution in Chikungunya&#x02014;What Decides the Outcome?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Srivastava</surname><given-names>Priyanshu</given-names></name><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/747553/overview"/></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Ankit</given-names></name><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/956982/overview"/></contrib><contrib contrib-type="author"><name><surname>Hasan</surname><given-names>Abdul</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/808982/overview"/></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Divya</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/747896/overview"/></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Ramesh</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/747902/overview"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Chetan</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/747850/overview"/></contrib><contrib contrib-type="author"><name><surname>Sunil</surname><given-names>Sujatha</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/653922/overview"/></contrib></contrib-group><aff><institution>Vector-Borne Diseases Group, International Centre for Genetic Engineering and Biotechnology (ICGEB)</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Lisa F. P. Ng, Singapore Immunology Network (A<sup>*</sup>STAR), Singapore</p></fn><fn fn-type="edited-by"><p>Reviewed by: Adam Taylor, Griffith University, Australia; Pierre Roques, CEA Saclay, France</p></fn><corresp id="c001">*Correspondence: Sujatha Sunil <email>sujatha@icgeb.res.in</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology</p></fn><fn fn-type="other" id="fn002"><p>&#x02020;These authors have contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>28</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>695</elocation-id><history><date date-type="received"><day>31</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Srivastava, Kumar, Hasan, Mehta, Kumar, Sharma and Sunil.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Srivastava, Kumar, Hasan, Mehta, Kumar, Sharma and Sunil</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Chikungunya disease (CHIKD) is a viral infection caused by an alphavirus, chikungunya virus (CHIKV), and triggers large outbreaks leading to epidemics. Despite the low mortality rate, it is a major public health concern owing to high morbidity in affected individuals. The complete spectrum of this disease can be divided into four phases based on its clinical presentation and immunopathology. When a susceptible individual is bitten by an infected mosquito, the bite triggers inflammatory responses attracting neutrophils and initiating a cascade of events, resulting in the entry of the virus into permissive cells. This phase is termed the pre-acute or the intrinsic incubation phase. The virus utilizes the cellular components of the innate immune system to enter into circulation and reach primary sites of infection such as the lymph nodes, spleen, and liver. Also, at this point, antigen-presenting cells (APCs) present the viral antigens to the T cells thereby activating and initiating adaptive immune responses. This phase is marked by the exhibition of clinical symptoms such as fever, rashes, arthralgia, and myalgia and is termed the acute phase of the disease. Viremia reaches its peak during this phase, thereby enhancing the antigen-specific host immune response. Simultaneously, T cell-mediated activation of B cells leads to the formation of CHIKV specific antibodies. Increase in titres of neutralizing IgG/IgM antibodies results in the clearance of virus from the bloodstream and marks the initiation of the post-acute phase. Immune responses mounted during this phase of the infection determine the degree of disease progression or its resolution. Some patients may progress to a chronic arthritic phase of the disease that may last from a few months to several years, owing to a compromised disease resolution. The present review discusses the immunopathology of CHIKD and the factors that dictate disease progression and its resolution.</p></abstract><kwd-group><kwd>chikungunya virus</kwd><kwd>incubation phase</kwd><kwd>acute phase</kwd><kwd>immunopathology</kwd><kwd>disease resolution</kwd><kwd>chronic phase</kwd><kwd>chikungunya induced arthritis</kwd><kwd>viral clearance</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">International Center for Genetic Engineering and Biotechnology<named-content content-type="fundref-id">10.13039/100007675</named-content></funding-source><award-id rid="cn001">Core Fund</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="0"/><equation-count count="0"/><ref-count count="189"/><page-count count="15"/><word-count count="12691"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Chikungunya disease (CHIKD), caused by an arthritogenic alphavirus, chikungunya virus (CHIKV), is becoming a major public health hazard (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). The past few decades have seen the re-emergence of this viral infection as evidenced by epidemics in Africa, Asia, Europe and, in recent years, the Americas (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). The first report of this infection dates back to the 1900s; it was then confused with dengue and was largely underreported (<xref rid="B5" ref-type="bibr">5</xref>). The latest outbreaks started during 2005 in the La Reunion islands where <italic>Aedes albopictus</italic> was the primary vector (<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>). It was identified that specific mutations in the viral E1 glycoprotein provided fitness to the virus by reducing its extrinsic incubation period within the mosquito and thereby was transmitted by the vector over a longer period of time (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Post-2005, the virus spread to different parts of the globe either by travelers or autochthonous outbreaks in tropical and temperate climates involving both mosquito species (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B11" ref-type="bibr">11</xref>).</p><p>CHIKD is primarily a viral infection manifested as a fever with severe arthritic joint involvement. Rightly so, the disease was named &#x0201c;Chikungunya,&#x0201d; which in Makonde means &#x0201c;that which bends up,&#x0201d; emphasizing the excruciating joint pain experienced by the affected individuals which disables movement (<xref rid="B12" ref-type="bibr">12</xref>). Even though the infection is classically characterized by fever and joint pains that last for up to a week and sequelae involving joint pains for a few weeks (<xref rid="B13" ref-type="bibr">13</xref>), the disease can last up to 2&#x02013;3 years in a small proportion of patients, affecting the joints and resulting in arthritis-like conditions (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). Recent outbreaks have reported neurological complications in patients stemming from the involvement of the central nervous system (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>) as well as an impaired immune system (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Furthermore, mortality owing to co-morbid conditions was also observed (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). The virus has also been reported to infect through vertical transmission between mother and unborn child and results in complications such as encephalopathy (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>).</p><p>CHIKD establishes itself and progresses to a prolonged malady involving the joints over a period of time. As the virus infects an individual, there is a period of intrinsic incubation before the clinical symptoms appear and the disease progresses. The disease can then be clinically categorized into acute, post-acute, and chronic phases that can last for a few days up to several months, mainly depending on the individual's immune response to the virus (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Several studies have established that host immunity can play an important role in disease progression and its resolution after an acute phase of the disease (<xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B28" ref-type="bibr">28</xref>). The innate immune system has shown to be protective, which may result in early resolution of the disease as evaluated in some reports (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). At the same time, components of adaptive immunity have been reported to be instrumental in mounting the severity of the disease and resulting in the chronic arthritic condition that could last for years (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). Recent research has attributed several viral factors that could also contribute to alleviated chronic conditions, such as persistence of defective viral particles in the host (<xref rid="B33" ref-type="bibr">33</xref>) and prolonged infection of synovial macrophages (<xref rid="B24" ref-type="bibr">24</xref>).</p><p>The current review is a chronological compilation of the immunopathological events that take place during the acute and post-acute phases of CHIKD that may either lead to resolution of the disease or contribute to an exaggerated immune response, resulting in a full-blown arthritic chronic phase lasting up-to several years (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Sequence of events during CHIKV infection: infected <italic>Aedes</italic> mosquito deposits the virus into the dermis and epidermis of the skin. The viral infection is characterized by an incubation period of which is followed by the acute phase during which a rapid rise in viremia occurs and clinical symptoms such as joint pain, fever, maculopapular and petechial rash appear. As the viral load increases the host innate and adaptive immune responses are evoked simultaneously. IgM and IgG levels rise and the virus is resolved from the host. Despite the robust host immune response, viral particles persist in the synovial fluid of joints and alter joint pathology resulting in a chronic phase that lasts for months/years.</p></caption><graphic xlink:href="fimmu-11-00695-g0001"/></fig></sec><sec id="s2"><title>Acute Phase</title><sec><title>Early Events Leading to the Establishment of CHIKV Infection</title><p>The pre-acute phase or the incubation period of CHIKD ranges from 2 to 12 days (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B34" ref-type="bibr">34</xref>&#x02013;<xref rid="B38" ref-type="bibr">38</xref>). As an infected mosquito takes a blood meal, it deposits the virus into the epidermis and dermis layers of the skin (<xref rid="B39" ref-type="bibr">39</xref>). At the same time, the mosquito also punctures nearby blood vessels, allowing the virus to enter the bloodstream as evidenced by the presence of virus in the sera as early as within 5 min of a mosquito bite (<xref rid="B40" ref-type="bibr">40</xref>). At the site of a mosquito bite, the resident cells of the cutaneous immune system defend the host from the pathogen. The cutaneous immune system acts as the first line of defense against the pathogen and is comprised of a heterogeneous mix of cells, such as the lymphocytes, dendritic cells (DCs), and monocytes (<xref rid="B39" ref-type="bibr">39</xref>). Gamma delta T lymphocytes (&#x003b3;&#x003b4; T cells) constitute the most abundant skin-resident T lymphocytes (<xref rid="B41" ref-type="bibr">41</xref>) and have demonstrated to play a critical role in cytotoxicity, cytokine secretion, and DC maturation and enhance their function (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). These cells are present in the skin, the local site of infection for CHIKV, and lack the major histocompatibility complex (MHC) restriction; therefore they do not require conventional antigen processing and thus can react to the unprocessed antigens (<xref rid="B43" ref-type="bibr">43</xref>). Infection of CHIKV in mice (footpad) led to a significant increase in the prevalence of this T cell subset in foot and popliteal lymph nodes (<xref rid="B44" ref-type="bibr">44</xref>). Further, mice deficient in &#x003b3;&#x003b4; T cells had an increased disease severity accompanied by histopathologic changes (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Skin resident dendritic cells such as langerhans cells encounter antigens at the site of infection and may disseminate the virus to draining lymph nodes where they interact with the effector T cells, resulting in the initiation of the adaptive immune response (<xref rid="B38" ref-type="bibr">38</xref>). Various studies (although contradictory in the explanation of mechanism) have documented the role of bite-induced enhancement of arboviral infection (<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B50" ref-type="bibr">50</xref>). Studies have indicated that mosquito saliva has immune-modulatory properties that enhance pathogen establishment within the host by limiting the host immune response (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>). One such study of CHIKV infection in mice models observed changes in cutaneous cytokine profiles when inoculating the virus with a needle or mimicking natural infection using mosquitoes. Needle inoculation of the virus into mice resulted in an increased expression of TLR3 and Th1 cytokines (IFN-&#x003b3; and IL2) whereas infection by mosquito bite elicited a Th2 cytokine response with an increase in IL4 and a reduction observed in TLR3, IFN-&#x003b3; and IL2 (<xref rid="B53" ref-type="bibr">53</xref>). In a different study carried out using dengue virus, similar IFN-&#x003b3; reduction was observed when the virus was inoculated with mosquito saliva as compared to direct needle inoculation of the virus (<xref rid="B54" ref-type="bibr">54</xref>). Similarly, research on the immune modulatory properties of mosquito saliva showed that mice previously sensitized with a salivary gland extract of mosquitoes have more robust cellular infiltration than non-sensitized mice. This study suggests that mosquito saliva has the ability to differentially regulate cellular microenvironment around the bite site (<xref rid="B55" ref-type="bibr">55</xref>). Another recent study correlated the initial events of mosquito bite and viral inoculation with subsequent development of systemic disease, highlighting an important role for cutaneous innate immune response. The study observed that stromal cells and macrophages were the main cellular targets for semliki forest virus replication at the initial bite sites, but these cells did not express markers of interferon induction upon infection. Dermal DC's, that are less abundant in the dermis, were major activators of type I IFN response at the initial inoculation site and therefore were major players in limiting viral replication and clinical progression (<xref rid="B56" ref-type="bibr">56</xref>).</p><p>However, other studies have argued that bite-induced enhancement is too early a process to activate and engage cells of the adaptive immune response (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B51" ref-type="bibr">51</xref>). Infections with Semliki forest virus aided or unaided by mosquito saliva showed no reduction in IFN-&#x003b3; levels, suggesting no perturbations of cutaneous antiviral immunity (<xref rid="B47" ref-type="bibr">47</xref>). The authors showed that in the presence of saliva, two major events were observed. First, the development of edema that retained the virus at the bite site thus delaying the dissemination of the virus to draining lymph nodes, slowing the initial innate immune response activation and enhancing cutaneous cell replication. Second, an influx of neutrophils attracted by cutaneous cells was observed beginning from 90 min of infection in the presence of mosquito saliva (<xref rid="B47" ref-type="bibr">47</xref>). Although neutrophils were themselves refractory to arboviral infection, they attracted cells of the myeloid lineage as new targets for viral replication. Myeloid cells are also responsible for spreading the virus from the initial site of infection, and neutrophil depletion at the bite site reduced viral dissemination (<xref rid="B47" ref-type="bibr">47</xref>). The importance of type I IFNs during early infection is evidenced by IFNAR-deficient mice models of CHIKV infection in which mice died within 3 days post CHIKV infection. Skin fibroblast cells upon infection by CHIKV virus were found to be major producers of type I IFNs (Specifically IFN-&#x003b2;). IFN production in these cells was triggered by the activation of extracellular as well as intracellular pathogen sensing receptors, such as TLR3 and MyD88, as a result of infection, thus leading to a strong anti-viral defense early during CHIKV infection (<xref rid="B57" ref-type="bibr">57</xref>).</p></sec><sec><title>Establishment of the Acute Phase of Infection</title><p>The beginning of the acute phase is marked by viral dissemination from the local site of replication to the primary sites of CHIKV infection in the host body (<xref rid="B24" ref-type="bibr">24</xref>). Hallmarks of the acute phase are peak viremia, manifestation of clinical symptoms, and production of neutralizing antibodies (<xref rid="B58" ref-type="bibr">58</xref>&#x02013;<xref rid="B60" ref-type="bibr">60</xref>). The acute phase of CHIKD typically lasts for 7&#x02013;14 days (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>). In both humans and murine models, the general observation is that CHIKV-induced immunopathology is considered the primary mediator of damage and persistent pain.</p><p>Viral replication in fibroblast cells (primary site of infection) is initially limited by a rapid and robust induction of interferons (IFN-&#x003b2;) and downstream signaling molecules. Interferons help to recruit immune cells that sense the viruses within the infected cells. This sensing may involve the specific pathogen-associated motifs like viral nucleic acids, that are recognized by pattern recognition molecules/receptors (PPRs); these receptors can be cytoplasmic [e.g., Class I&#x02014;NOD-like Receptors (NLRs), retinoic inducible gene-I like receptors (RLRs), melanoma differentiation factor (MDA)-5, laboratory of genetics and physiology (LGP)-2, cyclic GMP-AMP synthase (cGAS), Gamma-interferon-inducible (IFI) protein-16 and Class II&#x02014;Protein kinase R (PKR), DNA sensor AIM2 and 2&#x02032;-5&#x02032;-oligoadenylate synthase (OAS)-3] (<xref rid="B63" ref-type="bibr">63</xref>), or endosomal (e.g., Toll-like receptors; TLRs) (<xref rid="B64" ref-type="bibr">64</xref>). It was observed that inflammasome-specific molecules such as NLRP3 of the NLR family were associated with peak inflammatory symptoms during CHIKV infection and these effects could be reversed upon the usage of caspase-1 or NLRP3 inhibitors (<xref rid="B65" ref-type="bibr">65</xref>). Previously, the role of inflammasomes in CHIKV infection was explored through <italic>in-vitro</italic> studies using siRNA targeting caspase-1 that showed enhancement in CHIKV replication with silencing (<xref rid="B66" ref-type="bibr">66</xref>).</p><p>Members of RIG-1-like helicase families such as RIG-1 and MDA5 play a significant role in the activation of IFN-I response (<xref rid="B67" ref-type="bibr">67</xref>). These PPRs from Class I detect dsRNA or 5&#x02032;-triphosphate RNA in the cytosol and induce IFN production. It was shown that stimulation with 5&#x02032;-triphosphate RNA generates a robust antiviral response against CHIKV through RIG-1 pathway with the help of transcription factor IRF3 (<xref rid="B67" ref-type="bibr">67</xref>). Simultaneously, TLR3 gene expression was found to be significantly elevated and associated with up-regulation of several downstream molecules including IRF-1, IRF-3, IRF-7 and OAS-3, IFN-&#x003b2;, and TFN-&#x003b1; production (<xref rid="B68" ref-type="bibr">68</xref>). An association of TLR3 with CHIKV replication was shown by an agonist of TRIF-dependent signaling of interferon induction (<xref rid="B69" ref-type="bibr">69</xref>) and TRIF knockout mice showed high viral titer with increased foot swelling in comparison to WT infected mice (<xref rid="B70" ref-type="bibr">70</xref>). The role of TLR7 was also investigated by MyD88 knockout mice that showed high viremia but no difference in the severity of disease in comparison to WT infected mice (<xref rid="B70" ref-type="bibr">70</xref>), implying that MyD88 dependent pathway may not be involved in disease progression. However, another study showed a significant role of MyD88 signaling in controlling viral dissemination (<xref rid="B57" ref-type="bibr">57</xref>). Transcriptional analyses of peripheral blood from CHIKV infected patients showed a high expression of viperin in monocyte (<xref rid="B71" ref-type="bibr">71</xref>). The role of viperin was further evaluated using Rsad2 knockout mice that showed a significant direct correlation of the expression of this molecule with respect to higher viremia and joint inflammation (<xref rid="B71" ref-type="bibr">71</xref>).</p><p>Despite the robust and rapid immune response against the virus in permissive cells, CHIKV effectively evades the cellular control mechanisms. In fibroblast cells, for example, CHIKV dodges the interferon response by inducing a translational shut off (<xref rid="B27" ref-type="bibr">27</xref>). Additionally, the cytopathic nature of CHIKV induces apoptosis (<xref rid="B72" ref-type="bibr">72</xref>). Fibroblast and stromal cells, for example, undergo apoptosis within 24 h post-infection (<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>). The virus utilizes this cellular response to increase its rate of infection and since the viral particles are sequestered within the apoptotic blebs, it escapes recognition by the immune system. Engulfment of the apoptotic blebs by neighboring phagocytic cells such as macrophages promotes infection in a non-inflammatory or dormant manner (<xref rid="B74" ref-type="bibr">74</xref>). As the virus replicates, it simultaneously invades nearby blood vessels. Evidence has demonstrated the infection of blood monocytes by CHIKV virus (<xref rid="B75" ref-type="bibr">75</xref>). The virus continues replication, achieving a peak in viremia during the acute phase.</p></sec><sec><title>Immunopathology of Acute Phase</title><p>As CHIKV infection spreads, host immune responses are activated by engaging various subsets of myeloid cells as well as lymphocytes to control this spread. A major event in the acute phase is infiltration of macrophages, neutrophils, natural killer (NK) cells, and other lymphocytes to the primary sites of infection, mainly joints and muscles, leading to hypertrophy in the cells of synovial lining as well as surrounding synovial vessels (<xref rid="B76" ref-type="bibr">76</xref>) that manifests as arthralgia in the patients (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B77" ref-type="bibr">77</xref>). This cellular infiltration is mediated by pro-inflammatory cytokines and chemokines rich milieu at the sites of infection (<xref rid="B30" ref-type="bibr">30</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). CCL2 (MCP-1) is a major chemokine that is produced by various cell types like endothelial, fibroblasts, epithelial, smooth muscle, mesangial, astrocytic, monocytic, and microglial cells (<xref rid="B78" ref-type="bibr">78</xref>&#x02013;<xref rid="B81" ref-type="bibr">81</xref>). Macrophages, being the major source of CCL2, regulate the infiltration of monocytes and NK cells to the site of infection. Cessation in macrophage recruitment by using Bindarit, a modulator of CCL2 production, has shown reduced inflammation in synovial and skeletal muscle tissues (<xref rid="B82" ref-type="bibr">82</xref>). Another study showed contrasting results in which CCR2<sup>&#x02212;/&#x02212;</sup> mice exhibited increased foot swelling and cartilage erosion upon CHIKV infection (<xref rid="B83" ref-type="bibr">83</xref>). Macrophages are also known to be the reservoirs of CHIKV in later stages of infection (<xref rid="B24" ref-type="bibr">24</xref>), which possibly plays an important role in prolonged inflammation. CCR2 plays an important role in controlling inflammation and musculoskeletal pathology by maintaining the balance of monocytes and neutrophil infiltration to the infected tissues (<xref rid="B83" ref-type="bibr">83</xref>). CCR2<sup>&#x02212;/&#x02212;</sup> mice upon CHIKV infection showed enhanced arthritic symptoms without any significant change in viremia, as compared to wild type mice. Also, the monocyte/macrophage infiltrates were replaced by an enhanced neutrophil infiltration, followed by eosinophils infiltrates as well (<xref rid="B83" ref-type="bibr">83</xref>). These results suggest that neutrophils are one of the key mediators of arthritic symptoms and tissue damage in CHIKV infection by releasing granules carrying antimicrobial molecules and producing reactive oxygen species (ROS) due to an oxidative burst, which is also a well-established feature of neutrophils in other models of inflammation (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>). Neutrophils are also known to produce an anti-viral effect in an alternate way, by forming neutrophils extracellular traps (NETs) through a process called NETosis. <italic>In vitro</italic> CHIKV infection in neutrophils isolated from mice resulted in the formation of NETs through TLR7 and ROS dependent mechanism. Also, the correlation of NETosis with susceptibility and viral load has been shown in IFNAR<sup>&#x02212;/&#x02212;</sup> mice model and CHIKV infected patients, respectively, suggesting the anti-CHIKV role of NETosis (<xref rid="B86" ref-type="bibr">86</xref>). NETs are also known to activate plasmacytoid dendritic cells (pDCs), a subtype of dendritic cells, which secrete high levels of IFN-I (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>). In CHIKV infection, the virus is sensed by pDCs in an indirect manner that results in selective IRF7 activation and type-I IFN production without the involvement of other inflammatory cytokine responses (<xref rid="B89" ref-type="bibr">89</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Immune cell infiltration in CHIKV infected tissues: the primary target organs during CHIKV infection include liver, spleen, joints, and kidney. As the virus is disseminated to these sites during acute phase, it infects non-hematopoietic cells. Active viral replication within these cells generate viral dsRNA and ssRNA which is recognized by RLR and NLR leading to downstream activation of NF-&#x003ba;B and phosphorylation of IRF3 results in type-I IFNs and cytokine production within cells. Increase amount of IFNs in extracellular matrix activates IFNARs leading phosphorylation and dimerization of STAT1 and STAT2 in the presence of IRF9 results in activation of IFN stimulating genes. The presence of viral dsRNA and pro-inflammatory cytokines within these cells also activates OAS and PKR. Downstream of PKR activation is the generation of initiation factor eIF2a leading to a translational arrest. On the other hand, OAS once triggered generates RNase L which degrades viral RNA. In case of hematopoietic cells, endosomal TLRs recognize viral dsRNA. Downstream of TLR7, MyD88-IRAK-1-IRAF4-TRAF6 complex is recruited leading to phosphorylation of IkB. Likewise, signaling downstream of TLR3 involves the recruitment of TRIF. TRIF further interacts with TRAF6 and TRAF3. This complex recruits kinase RIP-1 triggering IRF3 and IRF7 phosphorylation downstream of TBK1 activation as well as IkB phosphorylation. These events lead to NF-&#x003ba;B dependent induction of pro-inflammatory cytokines, IFN-&#x003b1; and IFN-&#x003b2;. Cytokines within these cells also produce inflammasomes downstream of AIM2, which promotes apoptosis by cleaving pro-caspase1 to caspase1. Active IL-1&#x003b2; production is also enhanced during this event. The pro-inflammatory cytokines are also released extracellularly, generating a cytokine rich milieu and attracting other immune cells causing cellular infiltration. TLR, Toll-Like receptor; MyD88, myeloid differentiation primary response 88; TRAF, tumor necrosis factor receptor (TNFR)-associated factors; IKB, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; TRIF, TIR-domain-containing adapter-inducing interferon; IRF, interferon regulatory factor; TBK1, TANK-binding kinase 1; NF-&#x003ba;B, nuclear factor k-light-chain enhancer of activated B cells; IFN, interferons; RLR, RIG-1 like receptor; NLR, NOD-like receptor; OAS, 2&#x02032;5&#x02032; oligoadenylate synthetase; PKR, dsRNA-dependent protein kinase R; eIF2a, eukaryotic initiation factor 2 alpha subunit; RNase L, 2-5A dependent ribonuclease L; AIM2, absent in melanoma; IL-1&#x003b2;, Interleukine 1&#x003b2;; STAT, signal transducer and activator of transcription; IRF9, interferon regulatory factor 9; ISGF, IFN-stimulated gene factor; IFNAR, interferon-alpha/beta receptor.</p></caption><graphic xlink:href="fimmu-11-00695-g0002"/></fig><p>NK cells are also a major line of defense against the virus, displaying a marked change in surface receptor repertoire with increased expression of NKp44, CD57, ILT2, CD8&#x003b1;, and NKG2C and decreased expression of NKp30, NKp46, NKG2A, and CD16. Specifically, NKG2C cells undergo rapid expansion during the early acute phase of CHIKD and exert strong cytolytic response upon infected cells (<xref rid="B90" ref-type="bibr">90</xref>). As the disease progresses in CHIKD, terminally differentiated NK cells mature into CD56<sup>dim</sup>CD57<sup>+</sup> phenotype and show a strong cytolytic response and enhanced resistance to cytokine stimulation (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). It has been observed that the number of mature NK cells peak in the early acute phase (i.e., day 3 post-onset of symptoms) and their persistence is correlated with the viral load. Additionally, the persistence of these cells is also associated with chronic CHIKD (<xref rid="B90" ref-type="bibr">90</xref>).</p><p>In addition to the above mentioned pro-inflammatory mechanisms, the acute phase is also mediated by CD8<sup>+</sup> T cells responses at the early stages of infection while in the later stages it's the CD4<sup>+</sup> T cells that predominate the repertoire of the immune cells in humans (<xref rid="B92" ref-type="bibr">92</xref>). Murine studies have presented with the evidence that both CD4<sup>+</sup> and CD8<sup>+</sup> T cells infiltrate CHIKV-infected tissues during the course of infection (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>). These infiltrating T cells are understandably involved in mounting site-specific antiviral immune responses, contrary to which CD4<sup>+</sup> T cells have recently been shown to contribute toward the pathogenesis during CHIKV infection in mice without altering much of the viral titers along with IFN-&#x003b3; production (<xref rid="B95" ref-type="bibr">95</xref>).</p><p>During the acute phase, anti-CHIKV IgM could be detected in sera samples of patients and mice from day 3 onwards after the onset of clinical symptoms (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>) whereas the anti-CHIKV IgG with neutralizing activity is produced from day 4 (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B97" ref-type="bibr">97</xref>). Detection of Anti-CHIKV IgG is mostly rare during the initial days (&#x0003c;4 days) of infection (<xref rid="B97" ref-type="bibr">97</xref>). Several studies have also established a correlation between antibodies response with cytokine levels, viral titres, and disease progression during the acute and chronic phases (<xref rid="B97" ref-type="bibr">97</xref>, <xref rid="B98" ref-type="bibr">98</xref>). Patients with high virus titres in the acute phase or viremic phase triggered the production of Anti-CHIKV IgG3 antibodies which are strongly involved in protection against chronicity or arthralgia conditions whereas patients with low virus titres associated with chronic arthralgia (<xref rid="B99" ref-type="bibr">99</xref>). This suggested that high virus titres in the acute phase seem to induce high titer of Anti-CHIKV antibodies which protect against chronic stages of CHIKD (<xref rid="B99" ref-type="bibr">99</xref>). Additionally, CD4<sup>+</sup> null mice showed lower levels of anti-CHIKV antibodies along with significantly reduced neutralizing activity (<xref rid="B100" ref-type="bibr">100</xref>).</p><p>CHIKV infected cells are killed by the induction of cytolytic mechanisms along with the several antiviral factors by the immune cells, mainly CD8<sup>+</sup> T cells (<xref rid="B92" ref-type="bibr">92</xref>). Na&#x000ef;ve CD8<sup>+</sup> T cells induce a development environment upon activation leading to effector and memory T-cell proliferation and differentiation (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B59" ref-type="bibr">59</xref>). Once activated, effector CD8<sup>+</sup> T cells exhibit functions, such as cytotoxicity and cytokine production, against the virus, resulting in its elimination (<xref rid="B101" ref-type="bibr">101</xref>). Furthermore, it is known that CD8<sup>+</sup> T lymphocytes mediate cytolytic activity against target cells in two major pathways either by the release of cytolytic granules through exocytosis or granule independent pathway, in which they bind to the death receptors of the target cells (<xref rid="B102" ref-type="bibr">102</xref>). Studies have reported that the peripheral blood of acute and chronic CHIKD patients had no differences in the percentage of CD8<sup>+</sup> T cells in relation to healthy individuals. Analysis of early activation marker CD69 for CD8<sup>+</sup> T cells revealed increased CD8<sup>+</sup> T cell activation in both acute and chronic diseases (<xref rid="B103" ref-type="bibr">103</xref>). The study further observed that CD8<sup>+</sup> T lymphocytes in patients with acute CHIKD have increased secretion of CD107A along with granzyme and perforin expression in comparison to the control group, suggesting that CD8<sup>+</sup> T cells may have a role in mediating cytolytic killing of CHIKV infected cells during the acute phase of CHIKD (<xref rid="B103" ref-type="bibr">103</xref>). Interestingly, the CD8<sup>+</sup> T cells failed to present any such increase in the expression of granzyme and perforins in patients with chronic disease in comparison to healthy controls (<xref rid="B103" ref-type="bibr">103</xref>). Such observations point to the possibility that these mechanisms slow down or even shut off, owing to the process of T-cell exhaustion during the later stages of the disease.</p></sec></sec><sec id="s3"><title>Post-Acute Phase</title><sec><title>CHIKV Clearance</title><p>Clearance of CHIKV from blood paves the path to recovery in CHIKD patients and is comprised of various immune pathways constituting the post-acute phase of CHIKD. This phase is marked by complete clearance of active CHIKV from the body by neutralizing antibodies in the blood and destruction of infected cells by infiltrating NK cells, CD8<sup>+</sup> T cells, and neutrophils. Detection of neutralizing antibodies could begin from day 4 to 7 post-onset of symptoms and could last up to 3 weeks post clinical presentation. IgM antibodies could be detected during the acute phase of infection, whereas IgG antibodies are detected in the post-acute phase and may last for months (<xref rid="B104" ref-type="bibr">104</xref>&#x02013;<xref rid="B106" ref-type="bibr">106</xref>). Titres of neutralizing antibodies during the acute phase could predict the severity of CHIKD (<xref rid="B97" ref-type="bibr">97</xref>). Some patients are completely asymptomatic during the post-acute phase and recover completely. However, a majority of patients show temporary improvement in their clinical state and deterioration occurs after a short &#x0201c;healing&#x0201d; period (<xref rid="B61" ref-type="bibr">61</xref>). Also, a recent study using a C57BL/6J mice model has correlated viral clearance and development of IgG antibodies with age. It suggests that CHIKV neutralization and IgG titres were higher in 8-week-old mice during the acute phase, whereas CHIKV clearance was not observed until post-acute phase in 20 weeks old mice (<xref rid="B107" ref-type="bibr">107</xref>).</p><p>In the context of antibodies, detection of anti-CHIKV IgG is mostly rare during the acute phase of infection while detection occurs in the post-acute phase and persists for months or even years (<xref rid="B108" ref-type="bibr">108</xref>). Persistence of CHIKV specific IgM antibodies in the blood and synovial fluid is associated with severe chronic CHIKD (<xref rid="B109" ref-type="bibr">109</xref>&#x02013;<xref rid="B111" ref-type="bibr">111</xref>). IgG2c isotype is the major class of antibody produced in the case of CHIKV infected mice model due to IFN-&#x003b3; produced from CD4<sup>+</sup> T cells (<xref rid="B95" ref-type="bibr">95</xref>). Numerous reports have sought to characterize the neutralizing ability of CHIKV specific antibodies, and it has been reported in mice models as a therapeutic treatment against chikungunya persistence (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B112" ref-type="bibr">112</xref>&#x02013;<xref rid="B118" ref-type="bibr">118</xref>). In accordance with that, mice mutant Rag1<sup>&#x02212;/&#x02212;</sup> which lack B and T cells, leading to high viral titres in various tissues, concluded that chikungunya infection persists in tissues that are controlled by adaptive immune cells (<xref rid="B119" ref-type="bibr">119</xref>). Administration of polyclonal anti-CHIKV virus antisera in CHIKV infected RAG1<sup>&#x02212;/&#x02212;</sup> and B cell-deficient &#x003bc;MT mice resulted in clearance of the virus and could be not detected in blood (<xref rid="B25" ref-type="bibr">25</xref>). Similarly, administration of human monoclonal CHIKV-specific antibodies in chikungunya infected rhesus monkeys led to inhibition of viral spread and inflammatory responses in various tissues like joints and muscles (<xref rid="B116" ref-type="bibr">116</xref>).</p><p>Clearance of circulating pathogens from the system, though, generally involves opsonins like pathogen-specific antibodies and complement component 3 (C3) (<xref rid="B120" ref-type="bibr">120</xref>&#x02013;<xref rid="B122" ref-type="bibr">122</xref>). However, a recent study reports that clearance of CHIKV and RRV remains unaffected in the C3<sup>&#x02212;/&#x02212;</sup> and B cell-deficient &#x003bc;MT mice, suggesting the role of an uncharacterized innate immune pathway (<xref rid="B123" ref-type="bibr">123</xref>&#x02013;<xref rid="B125" ref-type="bibr">125</xref>). The other mechanism of clearance involves scavenger receptors (SRs), which is a non-opsonic mechanism known for the clearance of endogenous and microbial ligands (<xref rid="B126" ref-type="bibr">126</xref>, <xref rid="B127" ref-type="bibr">127</xref>). It was found that Kupffer cells found in the liver carry several SRs, out of which SR-A6 (MARCO) was identified as the key factor responsible for CHIKV clearance (<xref rid="B123" ref-type="bibr">123</xref>).</p></sec><sec><title>Disease Resolution</title><p>Chikungunya disease resolution is a combination of viral clearance from the host and resolution of inflammation, as all the major symptoms witnessed by the CHIKD patients are due to the robust pro-inflammatory host response. As discussed in the earlier parts of the review, viral clearance in the circulatory system is led by neutralizing antibodies, and virus replicating in the tissues is tackled by infiltrating pro-inflammatory cells like macrophages, CD8<sup>+</sup> T cells, neutrophils, and NK cells. The other arm of disease resolution, resolution of inflammation, is a complex network of events that strives to attain homeostasis post-inflammation and is regulated by a wide range of mediators (<xref rid="B128" ref-type="bibr">128</xref>&#x02013;<xref rid="B133" ref-type="bibr">133</xref>), and inadequate release of these mediators-of-resolution may lead to persistence of inflammation (<xref rid="B134" ref-type="bibr">134</xref>). In the case of CHIKV, proteomic profiling of CHIKV infected patients revealed a number of factors that mediate chemotaxis of neutrophils and phagocytes to be downregulated. Azurocidin (AZU1), annexin A1 (ANXA1), CTSG, S-100 calcium-binding proteins S100A7, S100A8, S100A9, and transforming growth factor beta 2 (TGFB2) are significantly downregulated mediators of inflammation found in CHIKV patients with 1&#x02013;10 days post-onset of symptoms (<xref rid="B133" ref-type="bibr">133</xref>). However, a phase-specific analysis of these mediators in CHIKV patients would provide better insight into the mechanism underneath the resolution of inflammation upon CHIKV infection. Also, RNA-seq analysis of feet and lymph nodes of CHIKV infected mice highlighted granzyme A as a major promoter of arthritic inflammation (<xref rid="B135" ref-type="bibr">135</xref>).</p><p>An important feature that decides resolution of the disease, mainly through regulation of inflammation of joints and attainment of homeostasis, is macrophage polarization and phenotype switching from M1 (pro-inflammatory) to M2 (anti-inflammatory). M1 macrophages restrict the proliferation of surrounding cells and damage infected tissues by releasing pro-inflammatory cytokines, whereas M2 macrophages promote multiplication of contiguous cells and tissue repair (<xref rid="B136" ref-type="bibr">136</xref>). This polarization and phenotype switching is regulated majorly by IRF/STAT signaling, tissue microenvironment (hypoxia), oligomerization domain (NOD)-like receptors, cytokine GM-CSF, and NF-&#x003ba;B signaling (<xref rid="B136" ref-type="bibr">136</xref>, <xref rid="B137" ref-type="bibr">137</xref>) and has been discussed in detail by Dr. Nan Wang (<xref rid="B136" ref-type="bibr">136</xref>). Macrophages exhibiting M2-like activation patterns are found in the CHIKV induced musculoskeletal inflammatory lesions (<xref rid="B138" ref-type="bibr">138</xref>) and are known to limit the pro-inflammatory immune response. Arginase 1 (Arg1) is an enzyme associated with M2 macrophages; upon genetic deletion of this enzyme tissue pathology was reduced and enhanced clearance of Ross River virus (RRV) was observed in mice model (<xref rid="B138" ref-type="bibr">138</xref>). These results suggest that M2 macrophages play an essential role in the resolution of inflammation, but at the same time M2 macrophages might support the persistence of CHIKV in the system leading to chronic disease. This hypothesis is supported by a study performed on a non-human primate model that suggests long term CHIKV persistence in the macrophages (<xref rid="B24" ref-type="bibr">24</xref>).</p><p>RNA interference (RNAi) controls the spatial and temporal regulation of the complex gene network involved in the immune response (<xref rid="B139" ref-type="bibr">139</xref>). Besides a significant function of silencing of genes related to diseases (<xref rid="B140" ref-type="bibr">140</xref>), the viral infection is an example of the complex interplay between viral RNA, endogenous miRNA, and host immune factors (<xref rid="B141" ref-type="bibr">141</xref>&#x02013;<xref rid="B144" ref-type="bibr">144</xref>). A recent report suggested that CHIKV establishes infections by regulating miRNA expression profile (<xref rid="B145" ref-type="bibr">145</xref>). miR15, miR-16, miR-17, let-7e, miR-125, miR-99, and miR-23a are altered during CHIKV infection which indicates that these act as biomarkers in chikungunya infection (<xref rid="B146" ref-type="bibr">146</xref>). Target analysis suggests that targets of these miRNAs are involved in the RIG-1 pathway, TGF-beta-signaling pathway, JAK&#x02013;STAT-signaling pathway, MAPK-signaling pathway, cytokine&#x02013;cytokine receptor interactions, and Fc gamma R-mediated phagocytosis (<xref rid="B145" ref-type="bibr">145</xref>). In addition, CHIKV infection in human synovial fibroblasts triggers the expression of miR-146a which downregulates the expression of TRAF6, IRAK1, and IRAK2 that in turn leads to decreased activation of NF-&#x003ba;B pathway by a negative feedback loop and promotes CHIKV replication (<xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B148" ref-type="bibr">148</xref>). Likewise, miRNAs are also known to participate in macrophage polarization. For example, miR-146a directly binds to the IRF transcription factors and (<xref rid="B149" ref-type="bibr">149</xref>, <xref rid="B150" ref-type="bibr">150</xref>) leads to suppression of inflammatory responses by promoting M2 switching. Similarly, miR-210 targets the NF-&#x003ba;B factors and elicits the suppression of M1 switching, resulting in suppression of inflammation (<xref rid="B151" ref-type="bibr">151</xref>&#x02013;<xref rid="B153" ref-type="bibr">153</xref>).</p><p>Other key players of CHIKD resolution are subsets of T cells, the regulatory T cells (Tregs), and Th17 cells. Differentiation of na&#x000ef;ve Th cells into Th17 and Tregs is a common signaling pathway arbitrated by TGF-&#x003b2;; however, the activation of these cells depends on the pro-inflammatory signals which also regulate the fate of these cells in a reciprocal manner (<xref rid="B154" ref-type="bibr">154</xref>). In the presence of IL-6 or IL-21, along with TGF-&#x003b2;, na&#x000ef;ve Th cells differentiate into Th17 cells, but in the absence of proinflammatory signals, TGF-&#x003b2; drives Treg differentiation (<xref rid="B155" ref-type="bibr">155</xref>&#x02013;<xref rid="B157" ref-type="bibr">157</xref>). Th17 cell produces IL-17, IL-22, and IL-23 that attracts neutrophils and hence promotes inflammation at the site of infection (<xref rid="B158" ref-type="bibr">158</xref>). In contrast, Treg produces cytokines IL-10 and TGF-&#x003b2;, which suppresses the activity of various immune cells and thereby induces anti-inflammatory responses. Expansion of Tregs, governed by enhanced IL-2 levels and antibody-mediated signaling, also inhibits CD4<sup>+</sup> effector T cell repertoire, resulting in alleviation of joint pathology (<xref rid="B159" ref-type="bibr">159</xref>). In this way, these two cells function in a yin and yang manner and maintain immune homeostasis during infection. It has been shown that the imbalance in cytokines, such as the increase in the concentration of IL-6 along with TGF-&#x003b2; which results in na&#x000ef;ve Th cells differentiating into Th17 cells (<xref rid="B160" ref-type="bibr">160</xref>), is a key player in arthritis and rheumatism (<xref rid="B161" ref-type="bibr">161</xref>). Several studies have shown a significant elevation in the levels of IL-1&#x003b2;, IL-6, and IL-17 associated with Th17 cells in both CHIKV infected humans and CHIKD mice models (<xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B162" ref-type="bibr">162</xref>, <xref rid="B163" ref-type="bibr">163</xref>). Conversely, a study conducted on the patient sera samples from Thailand 2009&#x02013;2010 outbreak showed no significant variations in IL-17 levels as compared to the healthy controls (<xref rid="B164" ref-type="bibr">164</xref>). Recent research on flavivirus using mouse model displaying the genetic diversity of the human population has, however, shown that the susceptibility of the host is not only affected by the viral sequence itself but is also controlled by multiple genes of the host (<xref rid="B165" ref-type="bibr">165</xref>). These studies suggest the need for detailed research unveiling the fundamental mechanisms involving immune cells and host genetic diversity as a whole in CHIKD resolution and inflammation.</p><p>Another class of regulatory cells that modulates the immune response by producing anti-inflammatory cytokines such as interleukin-10 (IL-10), IL-35, and transforming growth factor &#x003b2; (TGF-&#x003b2;) is a subset of B cells called regulatory B cells (Bregs) (<xref rid="B166" ref-type="bibr">166</xref>, <xref rid="B167" ref-type="bibr">167</xref>). Bregs cells inhibit the expansion of pro-inflammatory lymphocytes and other pathogenic T cells (<xref rid="B166" ref-type="bibr">166</xref>) by exerting the inhibitory effect on production of pro-inflammatory molecules, such as TNF-&#x003b1;, IFN-&#x003b3;, and IL-17 from CD4<sup>+</sup> T cells (<xref rid="B167" ref-type="bibr">167</xref>). However, Bregs also regulate the immune response by modulating the induction of cell death and IgM production, as reported both in humans and mice models (<xref rid="B168" ref-type="bibr">168</xref>&#x02013;<xref rid="B171" ref-type="bibr">171</xref>). CD9<sup>+</sup> Bregs stimulate differentiation of CD4<sup>+</sup> T cells into Tregs by producing high levels of TGF-&#x003b2; (<xref rid="B171" ref-type="bibr">171</xref>) which further alleviates the production of TNF-&#x003b1; and induces apoptosis in pro-inflammatory CD4<sup>+</sup> T cells. Production of IgM persuades elimination of apoptotic bodies, leading to reduction of pro-inflammatory mediators (<xref rid="B172" ref-type="bibr">172</xref>, <xref rid="B173" ref-type="bibr">173</xref>). Bregs have been studied for their role in rheumatoid arthritis (RA) and its regulation seems to be one of the key players that enhance RA disease (<xref rid="B174" ref-type="bibr">174</xref>, <xref rid="B175" ref-type="bibr">175</xref>). Considering that chikungunya-induced arthritis is an inflammatory response triggered by the virus that persists in joint tissues resulting in chronic rheumatoid disease (<xref rid="B1" ref-type="bibr">1</xref>), it is possible that Bregs might be involved in the regulation of chikungunya-induced RA via modulating inflammatory responses.</p></sec></sec><sec id="s4"><title>Chronic Phase</title><p>In several CHIKD cases, inflammation causing joints pain might persist for several months or years, resulting in symptoms similar to rheumatoid arthritis, and is termed as the chronic phase of CHIKD (<xref rid="B176" ref-type="bibr">176</xref>&#x02013;<xref rid="B178" ref-type="bibr">178</xref>). Typically, the chronic phase is characterized by joint swelling, joint stiffness, arthralgia, and tendonitis/tenosynovitis (<xref rid="B119" ref-type="bibr">119</xref>). Serologically, it marks a significant reduction of the virus as well as of viral RNA, reduced osteoprotegerin, and increased IL-6 and RANKL (receptor activator of NF-&#x003ba;B) ferritin, CRP (C-reactive protein), CXCL9, CXCL1, CHIKV-specific IgG titer IL-12 GM-CSF, IL-17, IL-27, IL-29, IL-8, MCP-1, MIP, CD95/CD95L, CXCL-9, and CXCL-10 (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B162" ref-type="bibr">162</xref>, <xref rid="B179" ref-type="bibr">179</xref>&#x02013;<xref rid="B182" ref-type="bibr">182</xref>). At this stage, CHIKV virus particles/viral RNA is cleared from the blood; however, studies have reported the persistence of CHIKV RNA in the macrophages (<xref rid="B24" ref-type="bibr">24</xref>) and fibroblast during chronic phase (<xref rid="B183" ref-type="bibr">183</xref>). Further, the viral dsRNA (intermediate stage during replication) found in the monocytes/macrophages of joints has been reported to trigger an arthritogenic response by activating NF-&#x003ba;B, both in <italic>in vitro</italic> studies (<xref rid="B76" ref-type="bibr">76</xref>), as well as in ankles and wrists of mice Rag<sup>&#x02212;/&#x02212;</sup> (<xref rid="B119" ref-type="bibr">119</xref>). Apart from RNA intermediates, studies have reported the persistence of CHIKV specific proteins in host cells over an extended period of time. CHIKV-nsP3 was found to be present as granules along the cell membrane in cells in persistent infection (<xref rid="B33" ref-type="bibr">33</xref>), while in another study, CHIKV-capsid proteins were evident in CHIKV infected mice as late as 60 days post-infection, suggesting the active translation of viral proteins during the chronic phase of CHIKD (<xref rid="B25" ref-type="bibr">25</xref>).</p><p>CD4<sup>+</sup> and CD8<sup>+</sup> T cells infiltrate the joints in CHIKD, causing inflammation. Specifically, CD4<sup>+</sup> T cells are majorly responsible for joint swelling and inflammation and possibly mediate inflammatory pathways through CD4<sup>+</sup> T-cell lineages, T<sub>H</sub>1 and T<sub>H</sub>2 cells that secrete anti-osteoclastogenic cytokines, IFN-&#x003b3;, and IL-4. The infiltration of T<sub>H</sub> 17 cells into the inflammatory joint links the abnormal T-cell response to bone damage in arthritis (<xref rid="B184" ref-type="bibr">184</xref>, <xref rid="B185" ref-type="bibr">185</xref>). One study found increased expression of CD95/CD95L in CD4<sup>+</sup> cells (<xref rid="B92" ref-type="bibr">92</xref>). In CD8<sup>+</sup> cells, although cells are nearly constant from healthy to acute to chronic phase, the persistent exposure of antigens to CD8<sup>+</sup> T cells leads to altered expression of biomarkers like CD69A, CD107A, and IL-17A (<xref rid="B103" ref-type="bibr">103</xref>). As CD8<sup>+</sup> T cells only express CD95L after activation (<xref rid="B186" ref-type="bibr">186</xref>), it can be safely assumed that these cells stay activated through the chronic phase, hence having a role in disease resolution and chronicity. Furthermore, effective immune cell activation drives the initial antiviral response leading to T-cell exhaustion, and this may be linked to viral persistence observed in the chronic phase (<xref rid="B26" ref-type="bibr">26</xref>). Additionally, the absence of CD8<sup>+</sup> T cells in synovial tissue may also be a contributing factor toward the persistence of CHIKV (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>Another hallmark of the chronic phase is bone erosion and degradation of extracellular matrix in joints, causing chronic arthralgia in CHIKD patients. Key players of the mechanism involved in bone erosion are resident macrophages, CCL2, IL-6, RANKL (<xref rid="B187" ref-type="bibr">187</xref>), osteoprotegerin, TRAF6, NFATc1, calcitonin receptors, cathepsin K, and &#x003b2;3 integrin (<xref rid="B184" ref-type="bibr">184</xref>, <xref rid="B188" ref-type="bibr">188</xref>); degradation of the extracellular matrix, meanwhile, is mediated by several factors such as fibroblast-like synoviocytes IL-1, TNF-&#x003b1;, Janus kinase, ERK, c-jun, and c-fos. These molecules, in turn, activate matrix metalloproteinases (MMP) in chondrocytes that promote extracellular matrix degradation during the chronic phase (<xref rid="B189" ref-type="bibr">189</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Chronic phase-CHIKV mediated joint pathology: in the joints, osteoblast cells (Bone-forming cells) are susceptible to CHIKV infection causing over-expression of IL-6 and RANKL and inhibition of osteoprotegerin (OPG). Also, fibroblast-like synoviocytes (HFLS) that are present in the synovial membrane lining the synovial joints, secrete enhanced levels of RANKL, IL-6, IL-8, and (MCP-1), upon CHIKV infection resulting in higher RANKL: OPG ratio, which favors osteoclast formation from precursor cells. RANKL and OPG maintain bone homeostasis as RANKL promotes osteoclastogenesis. RANKL recruits TRAF6 which induces auto amplification of NFATc1 (a transcription factor) via NF-&#x003ba;B and c-fos pathway and dependent on calcium signaling of ITAMs clastogenesis. NFATc1 in complex with AP-1 regulates the expression of genes involved in osteoclast differentiation e.g., calcitonin receptor, cathepsin K, and &#x003b2;3 integrin. Secretion of IL-1 and TNF-&#x003b1; by CHIKV infected resident macrophages phosphorylate JNK and ERK which in turn activates AP-1 family member, c-jun, which dimerize with c-fos and induce transcription of matrix metalloproteinases (MMP) that degrades components of extracellular matrix by collagenase activity.</p></caption><graphic xlink:href="fimmu-11-00695-g0003"/></fig></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>Complexities in CHIKD immunopathology in the host begins from the point of mosquito saliva that may contain both the virus as well as the viral antibodies that may affect the virus pathogenicity when delivered into the host during a bite. Furthermore, the immunomodulatory role of mosquito saliva is strikingly an understudied phenomenon in CHIKV infection. Does the mosquito saliva possess factors that can actively modulate viral pathogenesis? Can these molecules be utilized for developing novel antiviral strategies? How exactly does the presence of viral antibodies from previous bites affect CHIKV pathogenicity during the next bite to a na&#x000ef;ve individual? Even though some of these aspects have been looked into, in-depth studies are necessary to address these concerns more effectively. Additionally, answering some of these questions may help in arriving on novel transmission blocking strategies.</p><p>Once the infection is established, the innate and adaptive host immunity plays definitive roles in the progression of the disease that we know to be both protective as well as pathogenic in its response. These responses decide the clinical presentation of the disease at the febrile acute phase in terms of peak viremia, small joint and large joint involvement, as well as disease resolution during the post-acute phase. The current understanding of the subject suggests that arthritogenic symptoms in the acute phase of CHIKD are primarily due to pro-inflammatory host responses that could lead to the possible association of severe chronic cases with autoimmunity. Can we derive more knowledge regarding this association by looking into other similar autoimmune disorders such as rheumatoid arthritis? Will employing animal models specific to autoimmune disorders help in answering some immunological questions pertaining to immune response of CHIKV-induced arthritis? Can these systems recapitulate the actual pathogenesis seen in humans? How well are we using the clinical evidence to understand disease progression in the case of CHIKD? How do we use the information pertaining to inflammation more usefully in understanding CHIKD immunopathology? Can we devise intervention approaches based on this information pertaining to inflammation specifically to alleviate the arthritic phase?</p><p>The resolution of CHIKD is not yet fully understood and would be the most interesting area to be studied in future, as there are several well-established mediators of inflammation that have not been studied in the context of CHIKV chronic infections. This review has strived to emphasize the various immunological aspects that may lead to disease resolution/progression in CHIKD and highlight the lacuna present currently in the field.</p></sec><sec id="s6"><title>Author Contributions</title><p>SS: conceptualization, supervision, and funding acquisition. PS, AK, AH, DM, RK, CS, and SS: methodology, data curation, writing-original draft preparation, and writing-review and editing.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This research was funded by ICGEB Core funds.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhrbier</surname><given-names>A</given-names></name><name><surname>Jaffar-Bandjee</surname><given-names>C</given-names></name><name><surname>Gasque</surname><given-names>P</given-names></name></person-group>. <article-title>Arthritogenic alphaviruses&#x02014;an overview</article-title>. <source>Nat Rev Rheumatol</source>. (<year>2012</year>) <volume>8</volume>:<fpage>420</fpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2012.64</pub-id><?supplied-pmid 22565316?><pub-id pub-id-type="pmid">22565316</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahid</surname><given-names>B</given-names></name><name><surname>Ali</surname><given-names>A</given-names></name><name><surname>Rafique</surname><given-names>S</given-names></name><name><surname>Idrees</surname><given-names>M</given-names></name></person-group>. <article-title>Global expansion of chikungunya virus: mapping the 64-year history</article-title>. <source>Int J Infect Dis</source>. (<year>2017</year>) <volume>58</volume>:<fpage>69</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2017.03.006</pub-id><?supplied-pmid 28288924?><pub-id pub-id-type="pmid">28288924</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>AM</given-names></name><name><surname>Logue</surname><given-names>CH</given-names></name></person-group>. <article-title>Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus</article-title>. <source>J Genrl Virol</source>. (<year>2007</year>) <volume>88</volume>:<fpage>2363</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.82858-0</pub-id><?supplied-pmid 17698645?><pub-id pub-id-type="pmid">17698645</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name><surname>Nougairede</surname><given-names>A</given-names></name><name><surname>Cassadou</surname><given-names>S</given-names></name><name><surname>Prat</surname><given-names>C</given-names></name><name><surname>de Lamballerie</surname><given-names>X</given-names></name></person-group>. <article-title>Chikungunya in the Americas</article-title>. <source>Lancet</source>. (<year>2014</year>) <volume>383</volume>:<fpage>514</fpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60185-9</pub-id><?supplied-pmid 24506907?><pub-id pub-id-type="pmid">24506907</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>TR</given-names></name><name><surname>Carey</surname><given-names>DE</given-names></name><name><surname>Pavri</surname><given-names>KM</given-names></name></person-group>. <article-title>Preliminary isolation and identification of chikungunya virus from cases of dengue-like illness in Madras city</article-title>. <source>Indian J Med Res</source>. (<year>1965</year>) <volume>53</volume>:<fpage>689</fpage>&#x02013;<lpage>93</lpage>.<?supplied-pmid 5830402?><pub-id pub-id-type="pmid">5830402</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuffenecker</surname><given-names>I</given-names></name><name><surname>Iteman</surname><given-names>I</given-names></name><name><surname>Michault</surname><given-names>A</given-names></name><name><surname>Murri</surname><given-names>S</given-names></name><name><surname>Frangeul</surname><given-names>L</given-names></name><name><surname>Vaney</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak</article-title>. <source>PLoS Med</source>. (<year>2006</year>) <volume>3</volume>:<fpage>e263</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.0030263</pub-id><?supplied-pmid 16700631?><pub-id pub-id-type="pmid">16700631</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazeille</surname><given-names>M</given-names></name><name><surname>Moutailler</surname><given-names>S</given-names></name><name><surname>Coudrier</surname><given-names>D</given-names></name><name><surname>Rousseaux</surname><given-names>C</given-names></name><name><surname>Khun</surname><given-names>H</given-names></name><name><surname>Huerre</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Two chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus</article-title>. <source>PLoS ONE</source>. (<year>2007</year>) <volume>2</volume>:<fpage>e1168</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0001168</pub-id><?supplied-pmid 18000540?><pub-id pub-id-type="pmid">18000540</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazeille</surname><given-names>M</given-names></name><name><surname>Jeannin</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Schaffner</surname><given-names>FA</given-names></name><name><surname>Failloux</surname><given-names>B</given-names></name></person-group>. <article-title>Chikungunya: a risk for Mediterranean countries?</article-title>
<source>Acta Tropica</source>. (<year>2008</year>) <volume>105</volume>:<fpage>200</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2007.09.009</pub-id><?supplied-pmid 18005927?><pub-id pub-id-type="pmid">18005927</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsetsarkin</surname><given-names>KA</given-names></name><name><surname>Vanlandingham</surname><given-names>DL</given-names></name><name><surname>McGee</surname><given-names>CE</given-names></name><name><surname>Higgs</surname><given-names>S</given-names></name></person-group>. <article-title>A single mutation in chikungunya virus affects vector specificity and epidemic potential</article-title>. <source>PLoS Pathog.</source> (<year>2007</year>) <volume>3</volume>:<fpage>e201</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.0030201</pub-id><?supplied-pmid 18069894?><pub-id pub-id-type="pmid">18069894</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>SC</given-names></name><name><surname>Forrester</surname><given-names>NL</given-names></name></person-group>. <article-title>Chikungunya: evolutionary history and recent epidemic spread</article-title>. <source>Antiviral Res</source>. (<year>2015</year>) <volume>120</volume>:<fpage>32</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.04.016</pub-id><?supplied-pmid 25979669?><pub-id pub-id-type="pmid">25979669</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pialoux</surname><given-names>GB</given-names></name><name><surname>Ga&#x000fc;z&#x000e8;re</surname><given-names>A</given-names></name><name><surname>Jaur&#x000e9;guiberry</surname><given-names>S</given-names></name><name><surname>Strobel</surname><given-names>M</given-names></name></person-group>. <article-title>Chikungunya, an epidemic arbovirosis</article-title>. <source>Lancet Infect Dis</source>. (<year>2007</year>) <volume>7</volume>:<fpage>319</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(07)70107-X</pub-id><?supplied-pmid 17448935?><pub-id pub-id-type="pmid">17448935</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MC</given-names></name></person-group>
<article-title>An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952&#x02013;1953</article-title>. <source>Trans R Soc Trop Med Hyg.</source> (<year>1955</year>) <volume>49</volume>:<fpage>28</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/0035-9203(55)90080-8</pub-id><pub-id pub-id-type="pmid">14373834</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brighton</surname><given-names>S</given-names></name><name><surname>Prozesky</surname><given-names>O</given-names></name><name><surname>De La Harpe</surname><given-names>A</given-names></name></person-group>
<article-title>Chikungunya virus infection-A retrospective study of 107 cases</article-title>. <source>South African Med J</source>. (<year>1983</year>) <volume>68</volume>:<fpage>313</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgherini</surname><given-names>G</given-names></name><name><surname>Poubeau</surname><given-names>P</given-names></name><name><surname>Jossaume</surname><given-names>A</given-names></name><name><surname>Gouix</surname><given-names>A</given-names></name><name><surname>Cotte</surname><given-names>L</given-names></name><name><surname>Michault</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island</article-title>. <source>Clin Infect Dis</source>. (<year>2008</year>) <volume>47</volume>:<fpage>469</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1086/590003</pub-id><?supplied-pmid 18611153?><pub-id pub-id-type="pmid">18611153</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javelle</surname><given-names>E</given-names></name><name><surname>Ribera</surname><given-names>A</given-names></name><name><surname>Degasne</surname><given-names>I</given-names></name><name><surname>Ga&#x000fc;z&#x000e8;re</surname><given-names>A</given-names></name><name><surname>Marimoutou</surname><given-names>C</given-names></name><name><surname>Simon</surname><given-names>F</given-names></name></person-group>. <article-title>Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012</article-title>. <source>PLoS Neglect Trop D</source>. (<year>2015</year>) <volume>9</volume>:<fpage>e0003603</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0003603</pub-id><?supplied-pmid 25760632?><pub-id pub-id-type="pmid">25760632</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tournebize</surname><given-names>P</given-names></name><name><surname>Charlin</surname><given-names>C</given-names></name><name><surname>Lagrange</surname><given-names>M</given-names></name></person-group>. <article-title>Neurological manifestations in chikungunya: about 23 cases collected in Reunion Island</article-title>. <source>Rev Neurol</source>. (<year>2009</year>) <volume>165</volume>:<fpage>48</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurol.2008.06.009</pub-id><?supplied-pmid 18835614?><pub-id pub-id-type="pmid">18835614</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rampal</surname><given-names>MS</given-names></name><name><surname>Meena</surname><given-names>H</given-names></name></person-group>. <article-title>Neurological complications in chikungunya fever</article-title>. <source>J Assoc Physicians India.</source> (<year>2007</year>) <volume>55</volume>:<fpage>765</fpage>&#x02013;<lpage>9</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/article/MED/31312203#free-full-text">https://europepmc.org/article/MED/31312203#free-full-text</ext-link><?supplied-pmid 18290551?><pub-id pub-id-type="pmid">18290551</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balavoine</surname><given-names>S</given-names></name><name><surname>Pircher</surname><given-names>M</given-names></name><name><surname>Hoen</surname><given-names>B</given-names></name><name><surname>Herrmann-Storck</surname><given-names>C</given-names></name><name><surname>Najioullah</surname><given-names>F</given-names></name><name><surname>Madeux</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Guillain&#x02013;barr&#x000e9; syndrome and chikungunya: description of all cases diagnosed during the 2014. outbreak in the French West Indies</article-title>. <source>Am J Trop Med Hyg</source>. (<year>2017</year>) <volume>97</volume>:<fpage>356</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.15-0753</pub-id><?supplied-pmid 28722564?><pub-id pub-id-type="pmid">28722564</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>R</given-names></name><name><surname>Gerardin</surname><given-names>P</given-names></name><name><surname>de Brito</surname><given-names>CAA</given-names></name><name><surname>Soares</surname><given-names>CN</given-names></name><name><surname>Ferreira</surname><given-names>LB</given-names></name><name><surname>Solomon</surname><given-names>T</given-names></name></person-group>
<article-title>The neurological complications of chikungunya virus: a systematic review</article-title>. <source>Rev Med Virol</source>. (<year>2018</year>) <volume>28</volume>:<fpage>e1978</fpage>
<pub-id pub-id-type="doi">10.1002/rmv.1978</pub-id><pub-id pub-id-type="pmid">29671914</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renault</surname><given-names>P</given-names></name><name><surname>Solet</surname><given-names>JL</given-names></name><name><surname>Sissoko</surname><given-names>D</given-names></name><name><surname>Balleydier</surname><given-names>E</given-names></name><name><surname>Larrieu</surname><given-names>S</given-names></name><name><surname>Filleul</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006</article-title>. <source>Am J Trop Med Hyg</source>. (<year>2007</year>) <volume>77</volume>:<fpage>727</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2007.77.727</pub-id><?supplied-pmid 17978079?><pub-id pub-id-type="pmid">17978079</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CH</given-names></name><name><surname>Cruz-Lopez</surname><given-names>F</given-names></name><name><surname>Torres</surname><given-names>DV</given-names></name><name><surname>Perez-Padilla</surname><given-names>J</given-names></name><name><surname>Lorenzi</surname><given-names>OD</given-names></name><name><surname>Rivera</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Risk factors for hospitalization of patients with chikungunya virus infection at sentinel hospitals in Puerto Rico</article-title>. <source>PLoS Neglect Trop D</source>. (<year>2019</year>) <volume>13</volume>:<fpage>e0007084</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0007084</pub-id><?supplied-pmid 30640900?><pub-id pub-id-type="pmid">30640900</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramful</surname><given-names>D</given-names></name><name><surname>Carbonnier</surname><given-names>M</given-names></name><name><surname>Pasquet</surname><given-names>M</given-names></name><name><surname>Bouhmani</surname><given-names>B</given-names></name><name><surname>Ghazouani</surname><given-names>J</given-names></name><name><surname>Noormahomed</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Mother-to-child transmission of chikungunya virus infection</article-title>. <source>Pediatr Infect Dis J.</source> (<year>2007</year>) <volume>26</volume>:<fpage>811</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/INF.0b013e3180616d4f</pub-id><?supplied-pmid 17721376?><pub-id pub-id-type="pmid">17721376</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000e9;rardin</surname><given-names>P</given-names></name><name><surname>Barau</surname><given-names>G</given-names></name><name><surname>Michault</surname><given-names>A</given-names></name><name><surname>Bintner</surname><given-names>M</given-names></name><name><surname>Randrianaivo</surname><given-names>H</given-names></name><name><surname>Choker</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion</article-title>. <source>PLoS Med</source>. (<year>2008</year>) <volume>5</volume>:<fpage>e60</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.0050060</pub-id><?supplied-pmid 18351797?><pub-id pub-id-type="pmid">18351797</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labadie</surname><given-names>K</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Joubert</surname><given-names>C</given-names></name><name><surname>Mannioui</surname><given-names>A</given-names></name><name><surname>Delache</surname><given-names>B</given-names></name><name><surname>Brochard</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages</article-title>. <source>J Clin Invest</source>. (<year>2010</year>) <volume>120</volume>:<fpage>894</fpage>&#x02013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1172/JCI40104</pub-id><?supplied-pmid 20179353?><pub-id pub-id-type="pmid">20179353</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Rudd</surname><given-names>PA</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>JA</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Colle</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection</article-title>. <source>PLoS Neglect Trop Dis</source>. (<year>2014</year>) <volume>8</volume>:<fpage>e3354</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0003354</pub-id><?supplied-pmid 25474568?><pub-id pub-id-type="pmid">25474568</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoarau</surname><given-names>JJ</given-names></name><name><surname>Bandjee</surname><given-names>MCJ</given-names></name><name><surname>Trotot</surname><given-names>PK</given-names></name><name><surname>Das</surname><given-names>T</given-names></name><name><surname>Li-Pat-Yuen</surname><given-names>G</given-names></name><name><surname>Dassa</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>184</volume>:<fpage>5914</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900255</pub-id><?supplied-pmid 20404278?><pub-id pub-id-type="pmid">20404278</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>LK</given-names></name><name><surname>Sali</surname><given-names>T</given-names></name><name><surname>Alvarado</surname><given-names>D</given-names></name><name><surname>Gatti</surname><given-names>E</given-names></name><name><surname>Pierre</surname><given-names>P</given-names></name><name><surname>Streblow</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff</article-title>. <source>J Virol</source>. (<year>2011</year>) <volume>85</volume>:<fpage>606</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00767-10</pub-id><?supplied-pmid 20962078?><pub-id pub-id-type="pmid">20962078</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akahata</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Andersen</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Holdaway</surname><given-names>HA</given-names></name><name><surname>Kong</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection</article-title>. <source>Nat Med.</source> (<year>2010</year>) <volume>16</volume>:<fpage>334</fpage>. <pub-id pub-id-type="doi">10.1038/nm.2105</pub-id><?supplied-pmid 20111039?><pub-id pub-id-type="pmid">20111039</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpentier</surname><given-names>KS</given-names></name><name><surname>Morrison</surname><given-names>TE</given-names></name></person-group>. <article-title>Innate immune control of alphavirus infection</article-title>. <source>Curr Opin Virol</source>. (<year>2018</year>) <volume>28</volume>:<fpage>53</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2017.11.006</pub-id><?supplied-pmid 29175515?><pub-id pub-id-type="pmid">29175515</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>KM</given-names></name><name><surname>Heise</surname><given-names>MT</given-names></name></person-group>. <article-title>Protective and pathogenic responses to chikungunya virus infection</article-title>. <source>Curr Trop Med Rep</source>. (<year>2015</year>) <volume>2</volume>:<fpage>13</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1007/s40475-015-0037-z</pub-id><?supplied-pmid 26366337?><pub-id pub-id-type="pmid">26366337</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000e9;rardin</surname><given-names>P</given-names></name><name><surname>Fianu</surname><given-names>A</given-names></name><name><surname>Michault</surname><given-names>A</given-names></name><name><surname>Mussard</surname><given-names>C</given-names></name><name><surname>Boussa&#x000ef;d</surname><given-names>K</given-names></name><name><surname>Rollot</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Predictors of chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study</article-title>. <source>Arthritis Res Ther</source>. (<year>2013</year>) <volume>15</volume>:<fpage>R9</fpage>. <pub-id pub-id-type="doi">10.1186/ar4137</pub-id><?supplied-pmid 23302155?><pub-id pub-id-type="pmid">23302155</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoarau</surname><given-names>J-J</given-names></name><name><surname>Gay</surname><given-names>F</given-names></name><name><surname>Pell&#x000e9;</surname><given-names>O</given-names></name><name><surname>Samri</surname><given-names>A</given-names></name><name><surname>Jaffar-Bandjee</surname><given-names>M-C</given-names></name><name><surname>Gasque</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island</article-title>. <source>PLoS ONE</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e84695</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0084695</pub-id><?supplied-pmid 24376836?><pub-id pub-id-type="pmid">24376836</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remenyi</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Hughes</surname><given-names>RE</given-names></name><name><surname>Curd</surname><given-names>A</given-names></name><name><surname>Zothner</surname><given-names>C</given-names></name><name><surname>Peckham</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Persistent replication of a chikungunya virus replicon in human cells is associated with presence of stable cytoplasmic granules containing nonstructural protein 3</article-title>. <source>J Virol</source>. (<year>2018</year>) <volume>92</volume>:<fpage>e00477</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00477-18</pub-id><?supplied-pmid 29875241?><pub-id pub-id-type="pmid">29875241</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staples</surname><given-names>JE</given-names></name><name><surname>Breiman</surname><given-names>RF</given-names></name><name><surname>Powers</surname><given-names>AM</given-names></name></person-group>. <article-title>Chikungunya fever: an epidemiological review of a re-emerging infectious disease</article-title>. <source>Clin Infect Dis</source>. (<year>2009</year>) <volume>49</volume>:<fpage>942</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1086/605496</pub-id><?supplied-pmid 19663604?><pub-id pub-id-type="pmid">19663604</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>A</given-names></name><name><surname>Kiran</surname><given-names>D</given-names></name><name><surname>Manohar</surname><given-names>IC</given-names></name><name><surname>Kumar</surname><given-names>DP</given-names></name></person-group>. <article-title>Epidemiology, clinical manifestations, and diagnosis of chikungunya fever: lessons learned from the re-emerging epidemic</article-title>. <source>Indian J Dermatol</source>. (<year>2010</year>) <volume>55</volume>:<fpage>54</fpage>. <pub-id pub-id-type="doi">10.4103/0019-5154.60355</pub-id><?supplied-pmid 20418981?><pub-id pub-id-type="pmid">20418981</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanabe</surname><given-names>IS</given-names></name><name><surname>Tanabe</surname><given-names>EL</given-names></name><name><surname>Santos</surname><given-names>EC</given-names></name><name><surname>Martins</surname><given-names>WV</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>IM</given-names></name><name><surname>Cavalcante</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Cellular and molecular immune response to chikungunya virus infection</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2018</year>) <volume>8</volume>:<fpage>345</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00345</pub-id><?supplied-pmid 30364124?><pub-id pub-id-type="pmid">30364124</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>&#x000c1;lvarez-Arg&#x000fc;elles</surname><given-names>ME</given-names></name><name><surname>Alba</surname><given-names>SR</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>MR</given-names></name><name><surname>Riveiro</surname><given-names>JAB</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>SM</given-names></name></person-group>
<article-title>Diagnosis and molecular characterization of chikungunya virus infections</article-title>. In: Rodriguez-Morales AJ, editor. <source>Current Topics in Neglected Tropical Diseases.</source>
<publisher-loc>Colombia</publisher-loc>: <publisher-name>Intechopen</publisher-name> (<year>2019</year>). p. <fpage>34</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>BJ</given-names></name><name><surname>Sadanand</surname><given-names>S</given-names></name></person-group>. <article-title>Chikungunya infection: a re-emerging epidemic</article-title>. <source>Rheumatol Ther</source>. (<year>2018</year>) <volume>5</volume>:<fpage>317</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s40744-018-0121-7</pub-id><?supplied-pmid 30047016?><pub-id pub-id-type="pmid">30047016</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briant</surname><given-names>L</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P</given-names></name><name><surname>Choumet</surname><given-names>V</given-names></name><name><surname>Miss&#x000e9;</surname><given-names>D</given-names></name></person-group>. <article-title>Role of skin immune cells on the host susceptibility to mosquito-borne viruses</article-title>. <source>Virology</source>. (<year>2014</year>) <volume>464</volume>:<fpage>26</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2014.06.023</pub-id><?supplied-pmid 25043586?><pub-id pub-id-type="pmid">25043586</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Styer</surname><given-names>LM</given-names></name><name><surname>Kent</surname><given-names>KA</given-names></name><name><surname>Albright</surname><given-names>RG</given-names></name><name><surname>Bennett</surname><given-names>CJ</given-names></name><name><surname>Kramer</surname><given-names>LD</given-names></name><name><surname>Bernard</surname><given-names>KA</given-names></name></person-group>. <article-title>Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts</article-title>. <source>PLoS Pathog</source>. (<year>2007</year>) <volume>3</volume>:<fpage>1262</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.0030132</pub-id><?supplied-pmid 17941708?><pub-id pub-id-type="pmid">17941708</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayday</surname><given-names>AC</given-names></name></person-group>. <article-title>[gamma][delta] cells: a right time and a right place for a conserved third way of protection</article-title>. <source>Annu Rev Immunol.</source> (<year>2000</year>) <volume>18</volume>:<fpage>975</fpage>&#x02013;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.18.1.975</pub-id><?supplied-pmid 10837080?><pub-id pub-id-type="pmid">10837080</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Born</surname><given-names>W</given-names></name><name><surname>Cady</surname><given-names>C</given-names></name><name><surname>Jones-Carson</surname><given-names>J</given-names></name><name><surname>Mukasa</surname><given-names>A</given-names></name><name><surname>Lahn</surname><given-names>M</given-names></name><name><surname>O'brien</surname><given-names>R</given-names></name></person-group>
<article-title>Immunoregulatory functions of &#x003b3;<italic>&#x003b4;</italic> T cells</article-title>. <source>Adv Immunol.</source> (<year>1998</year>). <volume>71</volume>:<fpage>77</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-2776(08)60400-9</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carding</surname><given-names>SR</given-names></name><name><surname>Egan</surname><given-names>PJ</given-names></name></person-group>. <article-title>&#x003b3;<italic>&#x003b4;</italic> T cells: functional plasticity and heterogeneity</article-title>. <source>Nat Rev Immunol.</source> (<year>2002</year>) <volume>2</volume>:<fpage>336</fpage>. <pub-id pub-id-type="doi">10.1038/nri797</pub-id><?supplied-pmid 12033739?><pub-id pub-id-type="pmid">12033739</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>KM</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><name><surname>Whitmore</surname><given-names>AC</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>Thurlow</surname><given-names>LR</given-names></name><name><surname>McGee</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>&#x003b3;<italic>&#x003b4;</italic> T cells play a protective role in chikungunya virus-induced disease</article-title>. <source>J Virol.</source> (<year>2016</year>) <volume>90</volume>:<fpage>433</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02159-15</pub-id><?supplied-pmid 26491151?><pub-id pub-id-type="pmid">26491151</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>YX</given-names></name><name><surname>Roark</surname><given-names>CE</given-names></name><name><surname>Kelly</surname><given-names>K</given-names></name><name><surname>Drevets</surname><given-names>D</given-names></name><name><surname>Campbell</surname><given-names>P</given-names></name><name><surname>O'Brien</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Immune protection and control of inflammatory tissue necrosis by gamma delta T cells</article-title>. <source>J Immunol</source>. (<year>1994</year>) <volume>153</volume>:<fpage>3101</fpage>&#x02013;<lpage>15</lpage>.<?supplied-pmid 8089489?><pub-id pub-id-type="pmid">8089489</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>DCD</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Frank</surname><given-names>AA</given-names></name><name><surname>Mazzaccaro</surname><given-names>RJ</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group>. <article-title>An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis</article-title>. <source>J Immunol</source>. (<year>1997</year>) <volume>158</volume>:<fpage>1217</fpage>&#x02013;<lpage>21</lpage>.<?supplied-pmid 9013962?><pub-id pub-id-type="pmid">9013962</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pingen</surname><given-names>M</given-names></name><name><surname>Bryden</surname><given-names>SR</given-names></name><name><surname>Pondeville</surname><given-names>E</given-names></name><name><surname>Schnettler</surname><given-names>E</given-names></name><name><surname>Kohl</surname><given-names>A</given-names></name><name><surname>Merits</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Host inflammatory response to mosquito bites enhances the severity of arbovirus infection</article-title>. <source>Immunity</source>. (<year>2016</year>) <volume>44</volume>:<fpage>1455</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.002</pub-id><?supplied-pmid 27332734?><pub-id pub-id-type="pmid">27332734</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reagan</surname><given-names>KL</given-names></name><name><surname>Machain-Williams</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Blair</surname><given-names>CD</given-names></name></person-group>. <article-title>Immunization of mice with recombinant mosquito salivary protein D7 enhances mortality from subsequent West Nile virus infection via mosquito bite</article-title>. <source>PLoS Neglect Trop Dis</source>. (<year>2012</year>) <volume>6</volume>:<fpage>e1935</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0001935</pub-id><?supplied-pmid 23236530?><pub-id pub-id-type="pmid">23236530</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pingen</surname><given-names>M</given-names></name><name><surname>Schmid</surname><given-names>MA</given-names></name><name><surname>Harris</surname><given-names>E</given-names></name><name><surname>McKimmie</surname><given-names>CS</given-names></name></person-group>. <article-title>Mosquito biting modulates skin response to virus infection</article-title>. <source>Trends Parasitol</source>. (<year>2017</year>) <volume>33</volume>:<fpage>645</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2017.04.003</pub-id><?supplied-pmid 28495485?><pub-id pub-id-type="pmid">28495485</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>BS</given-names></name><name><surname>Higgs</surname><given-names>S</given-names></name></person-group>. <article-title>The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response</article-title>. <source>Trans R Soc Trop Med Hyg</source>. (<year>2008</year>) <volume>102</volume>:<fpage>400</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2008.01.024</pub-id><?supplied-pmid 18342898?><pub-id pub-id-type="pmid">18342898</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Styer</surname><given-names>LM</given-names></name><name><surname>Lim</surname><given-names>PY</given-names></name><name><surname>Louie</surname><given-names>KL</given-names></name><name><surname>Albright</surname><given-names>RG</given-names></name><name><surname>Kramer</surname><given-names>LD</given-names></name><name><surname>Bernard</surname><given-names>KA</given-names></name></person-group>. <article-title>Mosquito saliva causes enhancement of West Nile virus infection in mice</article-title>. <source>J Virol</source>. (<year>2011</year>) <volume>85</volume>:<fpage>1517</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01112-10</pub-id><?supplied-pmid 21147918?><pub-id pub-id-type="pmid">21147918</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>BS</given-names></name><name><surname>Soong</surname><given-names>L</given-names></name><name><surname>Zeidner</surname><given-names>NS</given-names></name><name><surname>Higgs</surname><given-names>S</given-names></name></person-group>. <article-title>Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection</article-title>. <source>Viral Immunol</source>. (<year>2004</year>) <volume>17</volume>:<fpage>565</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1089/vim.2004.17.565</pub-id><?supplied-pmid 15671753?><pub-id pub-id-type="pmid">15671753</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thangamani</surname><given-names>S</given-names></name><name><surname>Higgs</surname><given-names>S</given-names></name><name><surname>Ziegler</surname><given-names>S</given-names></name><name><surname>Vanlandingham</surname><given-names>D</given-names></name><name><surname>Tesh</surname><given-names>R</given-names></name><name><surname>Wikel</surname><given-names>S</given-names></name></person-group>. <article-title>Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus</article-title>. <source>PLoS ONE</source>. (<year>2010</year>) <volume>5</volume>:<fpage>e12137</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0012137</pub-id><?supplied-pmid 20711354?><pub-id pub-id-type="pmid">20711354</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname><given-names>M</given-names></name><name><surname>Christofferson</surname><given-names>R</given-names></name><name><surname>Grasperge</surname><given-names>B</given-names></name><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Chisenhall</surname><given-names>D</given-names></name><name><surname>Mores</surname><given-names>C</given-names></name></person-group>. <article-title>Aedes aegypti salivary protein aegyptin co-inoculation modulates dengue virus infection in the vertebrate host</article-title>. <source>Virology</source>. (<year>2014</year>) <volume>468</volume>:<fpage>133</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2014.07.019</pub-id><?supplied-pmid 25173089?><pub-id pub-id-type="pmid">25173089</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrique</surname><given-names>MO</given-names></name><name><surname>Neto</surname><given-names>LS</given-names></name><name><surname>Assis</surname><given-names>JB</given-names></name><name><surname>Barros</surname><given-names>MS</given-names></name><name><surname>Capurro</surname><given-names>ML</given-names></name><name><surname>Lepique</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>Evaluation of inflammatory skin infiltrate following Aedes aegypti bites in sensitized and non-sensitized mice reveals saliva-dependent and immune-dependent phenotypes</article-title>. <source>Immunology</source>. (<year>2019</year>) <volume>158</volume>:<fpage>47</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1111/imm.13096</pub-id><?supplied-pmid 31315156?><pub-id pub-id-type="pmid">31315156</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryden</surname><given-names>SR</given-names></name><name><surname>Pingen</surname><given-names>M</given-names></name><name><surname>Lefteri</surname><given-names>DA</given-names></name><name><surname>Miltenburg</surname><given-names>J</given-names></name><name><surname>Delang</surname><given-names>L</given-names></name><name><surname>Jacobs</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site</article-title>. <source>Sci Transl Med.</source> (<year>2020</year>) <volume>12</volume>:<fpage>eaax2421</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aax2421</pub-id><?supplied-pmid 31969486?><pub-id pub-id-type="pmid">31969486</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilte</surname><given-names>C</given-names></name><name><surname>Couderc</surname><given-names>T</given-names></name><name><surname>Chretien</surname><given-names>F</given-names></name><name><surname>Sourisseau</surname><given-names>M</given-names></name><name><surname>Gangneux</surname><given-names>N</given-names></name><name><surname>Guivel-Benhassine</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Type I IFN controls chikungunya virus via its action on nonhematopoietic cells</article-title>. <source>J Exp Med</source>. (<year>2010</year>) <volume>207</volume>:<fpage>429</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20090851</pub-id><?supplied-pmid 20123960?><pub-id pub-id-type="pmid">20123960</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>V</given-names></name><name><surname>Binn</surname><given-names>L</given-names></name><name><surname>Randall</surname><given-names>R</given-names></name></person-group>. <article-title>Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues</article-title>. <source>Am J Trop Med Hyg</source>. (<year>1967</year>) <volume>16</volume>:<fpage>786</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.1967.16.786</pub-id><?supplied-pmid 4965219?><pub-id pub-id-type="pmid">4965219</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>O</given-names></name><name><surname>Albert</surname><given-names>ML</given-names></name></person-group>. <article-title>Biology and pathogenesis of chikungunya virus</article-title>. <source>Nat Rev Microbiol</source>. (<year>2010</year>) <volume>8</volume>:<fpage>491</fpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2368</pub-id><?supplied-pmid 20551973?><pub-id pub-id-type="pmid">20551973</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Galaz-Montoya</surname><given-names>JG</given-names></name><name><surname>Sherman</surname><given-names>MB</given-names></name><name><surname>Sun</surname><given-names>SY</given-names></name><name><surname>Goldsmith</surname><given-names>CS</given-names></name><name><surname>O'Toole</surname><given-names>ET</given-names></name><etal/></person-group>. <article-title>Neutralizing antibodies inhibit chikungunya virus budding at the plasma membrane</article-title>. <source>Cell Host Microbe</source>. (<year>2018</year>) <volume>24</volume>:<fpage>417</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2018.07.018</pub-id><?supplied-pmid 30146390?><pub-id pub-id-type="pmid">30146390</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Cunha</surname><given-names>RV</given-names></name><name><surname>Trinta</surname><given-names>KS</given-names></name></person-group>
<article-title>Chikungunya virus: clinical aspects and treatment-a review</article-title>. <source>Mem Inst Oswaldo Cruz</source>. (<year>2017</year>) <volume>112</volume>:<fpage>523</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1590/0074-02760170044</pub-id><pub-id pub-id-type="pmid">28767976</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>DL</given-names></name><name><surname>Duarte</surname><given-names>ALBP</given-names></name><name><surname>Ranzolin</surname><given-names>A</given-names></name><name><surname>Dantas</surname><given-names>AT</given-names></name><name><surname>Cavalcanti</surname><given-names>NG</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>SG</given-names></name><etal/></person-group>. <article-title>Recommendations of the Brazilian Society of Rheumatology for diagnosis and treatment of chikungunya fever. Part 1-Diagnosis and special situations</article-title>. <source>Rev Bras Reumatol Engl Ed</source>. (<year>2017</year>) <volume>57</volume>:<fpage>s421</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbre.2017.05.006</pub-id><?supplied-pmid 28751131?><pub-id pub-id-type="pmid">28751131</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habjan</surname><given-names>M</given-names></name><name><surname>Pichlmair</surname><given-names>A</given-names></name></person-group>. <article-title>Cytoplasmic sensing of viral nucleic acids</article-title>. <source>Curr Opin Virol</source>. (<year>2015</year>) <volume>11</volume>:<fpage>31</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2015.01.012</pub-id><?supplied-pmid 25668758?><pub-id pub-id-type="pmid">25668758</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>S</given-names></name><name><surname>Thomsen</surname><given-names>AR</given-names></name></person-group>. <article-title>Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion</article-title>. <source>J Virol</source>. (<year>2012</year>) <volume>86</volume>:<fpage>2900</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.05738-11</pub-id><?supplied-pmid 22258243?><pub-id pub-id-type="pmid">22258243</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Foo</surname><given-names>SS</given-names></name><name><surname>Zaid</surname><given-names>A</given-names></name><name><surname>Teng</surname><given-names>TS</given-names></name><name><surname>Herrero</surname><given-names>LJ</given-names></name><name><surname>Wolf</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation</article-title>. <source>Nat Microbiol</source>. (<year>2017</year>) <volume>2</volume>:<fpage>1435</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-017-0015-4</pub-id><?supplied-pmid 28848230?><pub-id pub-id-type="pmid">28848230</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekchariyawat</surname><given-names>P</given-names></name><name><surname>Hamel</surname><given-names>R</given-names></name><name><surname>Bernard</surname><given-names>E</given-names></name><name><surname>Wichit</surname><given-names>S</given-names></name><name><surname>Surasombatpattana</surname><given-names>P</given-names></name><name><surname>Talignani</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Inflammasome signaling pathways exert antiviral effect against chikungunya virus in human dermal fibroblasts</article-title>. <source>Infect Genet Evol</source>. (<year>2015</year>) <volume>32</volume>:<fpage>401</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2015.03.025</pub-id><?supplied-pmid 25847693?><pub-id pub-id-type="pmid">25847693</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olagnier</surname><given-names>D</given-names></name><name><surname>Scholte</surname><given-names>FE</given-names></name><name><surname>Chiang</surname><given-names>C</given-names></name><name><surname>Albulescu</surname><given-names>IC</given-names></name><name><surname>Nichols</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response</article-title>. <source>J Virol</source>. (<year>2014</year>) <volume>88</volume>:<fpage>4180</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.03114-13</pub-id><?supplied-pmid 24478443?><pub-id pub-id-type="pmid">24478443</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priya</surname><given-names>R</given-names></name><name><surname>Patro</surname><given-names>I</given-names></name><name><surname>Parida</surname><given-names>M</given-names></name></person-group>. <article-title>TLR3 mediated innate immune response in mice brain following infection with chikungunya virus</article-title>. <source>Virus Res</source>. (<year>2014</year>) <volume>189</volume>:<fpage>194</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2014.05.010</pub-id><?supplied-pmid 24905288?><pub-id pub-id-type="pmid">24905288</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryke</surname><given-names>KM</given-names></name><name><surname>Abraham</surname><given-names>J</given-names></name><name><surname>Sali</surname><given-names>TM</given-names></name><name><surname>Gall</surname><given-names>BJ</given-names></name><name><surname>Archer</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>A novel agonist of the TRIF pathway induces a cellular state refractory to replication of Zika, chikungunya, and dengue viruses</article-title>. <source>MBio</source>. (<year>2017</year>) <volume>8</volume>:<fpage>e00452</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00452-17</pub-id><?supplied-pmid 28465426?><pub-id pub-id-type="pmid">28465426</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname><given-names>PA</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Babarit</surname><given-names>C</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><etal/></person-group>. <article-title>Interferon response factors 3 and 7 protect against chikungunya virus hemorrhagic fever and shock</article-title>. <source>J Virol</source>. (<year>2012</year>) <volume>86</volume>:<fpage>9888</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00956-12</pub-id><?supplied-pmid 22761364?><pub-id pub-id-type="pmid">22761364</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>TS</given-names></name><name><surname>Foo</surname><given-names>S</given-names></name><name><surname>Simamarta</surname><given-names>D</given-names></name><name><surname>Lum</surname><given-names>FM</given-names></name><name><surname>Teo</surname><given-names>TH</given-names></name><name><surname>Lulla</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Viperin restricts chikungunya virus replication and pathology</article-title>. <source>J Clin Invest.</source> (<year>2012</year>) <volume>122</volume>:<fpage>4447</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1172/JCI63120</pub-id><?supplied-pmid 23160199?><pub-id pub-id-type="pmid">23160199</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sourisseau</surname><given-names>M</given-names></name><name><surname>Schilte</surname><given-names>C</given-names></name><name><surname>Casartelli</surname><given-names>N</given-names></name><name><surname>Trouillet</surname><given-names>C</given-names></name><name><surname>Guivel-Benhassine</surname><given-names>F</given-names></name><name><surname>Rudnicka</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Characterization of reemerging chikungunya virus</article-title>. <source>PLoS Pathog.</source> (<year>2007</year>) <volume>3</volume>:<fpage>e89</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.0030089</pub-id><?supplied-pmid 17604450?><pub-id pub-id-type="pmid">17604450</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wikan</surname><given-names>N</given-names></name><name><surname>Sakoonwatanyoo</surname><given-names>P</given-names></name><name><surname>Ubol</surname><given-names>S</given-names></name><name><surname>Yoksan</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>DR</given-names></name></person-group>. <article-title>Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage</article-title>. <source>PLoS ONE</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e31102</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0031102</pub-id><?supplied-pmid 22299053?><pub-id pub-id-type="pmid">22299053</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krejbich-Trotot</surname><given-names>P</given-names></name><name><surname>Gay</surname><given-names>B</given-names></name><name><surname>Li-Pat-Yuen</surname><given-names>G</given-names></name><name><surname>Hoarau</surname><given-names>JJ</given-names></name><name><surname>Jaffar-Bandjee</surname><given-names>MC</given-names></name><name><surname>Briant</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Chikungunya triggers an autophagic process which promotes viral replication</article-title>. <source>Virol J</source>. (<year>2011</year>) <volume>8</volume>:<fpage>432</fpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-8-432</pub-id><?supplied-pmid 21902836?><pub-id pub-id-type="pmid">21902836</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Her</surname><given-names>Z</given-names></name><name><surname>Malleret</surname><given-names>B</given-names></name><name><surname>Chan</surname><given-names>M</given-names></name><name><surname>Ong</surname><given-names>EK</given-names></name><name><surname>Wong</surname><given-names>S-C</given-names></name><name><surname>Kwek</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>Active infection of human blood monocytes by chikungunya virus triggers an innate immune response</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>184</volume>:<fpage>5903</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0904181</pub-id><?supplied-pmid 20404274?><pub-id pub-id-type="pmid">20404274</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zare</surname><given-names>F</given-names></name><name><surname>Bokarewa</surname><given-names>M</given-names></name><name><surname>Nenonen</surname><given-names>N</given-names></name><name><surname>Bergstrom</surname><given-names>T</given-names></name><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Arthritogenic properties of double-stranded (viral) RNA</article-title>. <source>J Immunol</source>. (<year>2004</year>) <volume>172</volume>:<fpage>5656</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.172.9.5656</pub-id><?supplied-pmid 15100310?><pub-id pub-id-type="pmid">15100310</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis-Maguiraga</surname><given-names>L</given-names></name><name><surname>Noret</surname><given-names>M</given-names></name><name><surname>Brun</surname><given-names>S</given-names></name><name><surname>Le Grand</surname><given-names>R</given-names></name><name><surname>Gras</surname><given-names>G</given-names></name><name><surname>Roques</surname><given-names>P</given-names></name></person-group>. <article-title>Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia</article-title>. <source>PLoS Negl Trop Dis</source>. (<year>2012</year>) <volume>6</volume>:<fpage>e1446</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0001446</pub-id><?supplied-pmid 22479654?><pub-id pub-id-type="pmid">22479654</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushing</surname><given-names>SD</given-names></name><name><surname>Berliner</surname><given-names>JA</given-names></name><name><surname>Valente</surname><given-names>AJ</given-names></name><name><surname>Territo</surname><given-names>MC</given-names></name><name><surname>Navab</surname><given-names>M</given-names></name><name><surname>Parhami</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>1990</year>) <volume>87</volume>:<fpage>5134</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.87.13.5134</pub-id><?supplied-pmid 1695010?><pub-id pub-id-type="pmid">1695010</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Standiford</surname><given-names>TJ</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Phan</surname><given-names>SH</given-names></name><name><surname>Rollins</surname><given-names>BJ</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name></person-group>. <article-title>Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells</article-title>. <source>J Biol Chem</source>. (<year>1991</year>) <volume>266</volume>:<fpage>9912</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 2033076?><pub-id pub-id-type="pmid">2033076</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>Z</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Neild</surname><given-names>GH</given-names></name><name><surname>Thompson</surname><given-names>RC</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Westwick</surname><given-names>J</given-names></name></person-group>. <article-title>IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells</article-title>. <source>Kidney Int</source>. (<year>1992</year>) <volume>42</volume>:<fpage>95</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1038/ki.1992.266</pub-id><?supplied-pmid 1386129?><pub-id pub-id-type="pmid">1386129</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barna</surname><given-names>BP</given-names></name><name><surname>Pettay</surname><given-names>J</given-names></name><name><surname>Barnett</surname><given-names>GH</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Iwasaki</surname><given-names>K</given-names></name><name><surname>Estes</surname><given-names>ML</given-names></name></person-group>. <article-title>Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor</article-title>. <source>J Neuroimmunol</source>. (<year>1994</year>) <volume>50</volume>:<fpage>101</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/0165-5728(94)90220-8</pub-id><?supplied-pmid 8300851?><pub-id pub-id-type="pmid">8300851</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rulli</surname><given-names>NE</given-names></name><name><surname>Rolph</surname><given-names>MS</given-names></name><name><surname>Srikiatkhachorn</surname><given-names>A</given-names></name><name><surname>Anantapreecha</surname><given-names>S</given-names></name><name><surname>Guglielmotti</surname><given-names>A</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name></person-group>. <article-title>Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis</article-title>. <source>J Infect Dis</source>. (<year>2011</year>) <volume>204</volume>:<fpage>1026</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jir470</pub-id><?supplied-pmid 21881117?><pub-id pub-id-type="pmid">21881117</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poo</surname><given-names>YS</given-names></name><name><surname>Nakaya</surname><given-names>H</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Schroder</surname><given-names>WA</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><etal/></person-group>. <article-title>CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis</article-title>. <source>J Virol</source>. (<year>2014</year>) <volume>88</volume>:<fpage>6862</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.03364-13</pub-id><?supplied-pmid 24696480?><pub-id pub-id-type="pmid">24696480</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000f6;nrich</surname><given-names>G</given-names></name><name><surname>Raftery</surname><given-names>MJ</given-names></name></person-group>. <article-title>Neutrophil extracellular traps go viral</article-title>. <source>Front Immunol</source>. (<year>2016</year>) <volume>7</volume>:<fpage>366</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00366</pub-id><?supplied-pmid 27698656?><pub-id pub-id-type="pmid">27698656</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Ha</surname><given-names>B</given-names></name><name><surname>Zen</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group>. <article-title>Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions</article-title>. <source>J Immunol</source>. (<year>2012</year>) <volume>188</volume>:<fpage>844</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1101736</pub-id><?supplied-pmid 22156344?><pub-id pub-id-type="pmid">22156344</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiroki</surname><given-names>CH</given-names></name><name><surname>Toller-Kawahisa</surname><given-names>JE</given-names></name><name><surname>Fumagalli</surname><given-names>MJ</given-names></name><name><surname>Col&#x000f3;n</surname><given-names>DF</given-names></name><name><surname>Figueiredo</surname><given-names>LT</given-names></name><name><surname>Fonseca</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>Neutrophil extracellular traps effectively control acute chikungunya virus infection</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>3108</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.03108</pub-id><?supplied-pmid 32082301?><pub-id pub-id-type="pmid">32082301</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lande</surname><given-names>R</given-names></name><name><surname>Ganguly</surname><given-names>D</given-names></name><name><surname>Facchinetti</surname><given-names>V</given-names></name><name><surname>Frasca</surname><given-names>L</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Gregorio</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA&#x02013;peptide complexes in systemic lupus erythematosus</article-title>. <source>Sci Transl Med</source>. (<year>2011</year>) <volume>3</volume>:<fpage>73ra19</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3001180</pub-id><?supplied-pmid 21389263?><pub-id pub-id-type="pmid">21389263</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiecki</surname><given-names>M</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group>. <article-title>The multifaceted biology of plasmacytoid dendritic cells</article-title>. <source>Nat Rev Immunol</source>. (<year>2015</year>) <volume>15</volume>:<fpage>471</fpage>. <pub-id pub-id-type="doi">10.1038/nri3865</pub-id><?supplied-pmid 26160613?><pub-id pub-id-type="pmid">26160613</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>B</given-names></name><name><surname>Werneke</surname><given-names>SW</given-names></name><name><surname>Zafirova</surname><given-names>B</given-names></name><name><surname>This</surname><given-names>S</given-names></name><name><surname>Col&#x000e9;on</surname><given-names>S</given-names></name><name><surname>Decembre</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Plasmacytoid dendritic cells control dengue and chikungunya virus infections via IRF7-regulated interferon responses</article-title>. <source>Elife</source>. (<year>2018</year>) <volume>7</volume>:<fpage>e34273</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.34273</pub-id><?supplied-pmid 29914621?><pub-id pub-id-type="pmid">29914621</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitdemange</surname><given-names>C</given-names></name><name><surname>Becquart</surname><given-names>P</given-names></name><name><surname>Wauquier</surname><given-names>N</given-names></name><name><surname>Beziat</surname><given-names>V</given-names></name><name><surname>Debre</surname><given-names>P</given-names></name><name><surname>Leroy</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity</article-title>. <source>PLoS Pathog</source>. (<year>2011</year>) <volume>7</volume>:<fpage>e1002268</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002268</pub-id><?supplied-pmid 21966274?><pub-id pub-id-type="pmid">21966274</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>CM</given-names></name><name><surname>White</surname><given-names>MJ</given-names></name><name><surname>Goodier</surname><given-names>MR</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group>. <article-title>Functional significance of CD57 expression on human NK cells and relevance to disease</article-title>. <source>Front Immunol</source>. (<year>2013</year>) <volume>4</volume>:<fpage>422</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00422</pub-id><?supplied-pmid 24367364?><pub-id pub-id-type="pmid">24367364</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wauquier</surname><given-names>N</given-names></name><name><surname>Becquart</surname><given-names>P</given-names></name><name><surname>Nkoghe</surname><given-names>D</given-names></name><name><surname>Padilla</surname><given-names>C</given-names></name><name><surname>Ndjoyi-Mbiguino</surname><given-names>A</given-names></name><name><surname>Leroy</surname><given-names>EM</given-names></name></person-group>. <article-title>The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation</article-title>. <source>J Infect Dis</source>. (<year>2011</year>) <volume>204</volume>:<fpage>115</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiq006</pub-id><?supplied-pmid 21628665?><pub-id pub-id-type="pmid">21628665</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Anraku</surname><given-names>I</given-names></name><name><surname>Le</surname><given-names>TT</given-names></name><name><surname>Larcher</surname><given-names>T</given-names></name><name><surname>Major</surname><given-names>L</given-names></name><name><surname>Roques</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Chikungunya virus arthritis in adult wild-type mice</article-title>. <source>J Virol</source>. (<year>2010</year>) <volume>84</volume>:<fpage>8021</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02603-09</pub-id><?supplied-pmid 20519386?><pub-id pub-id-type="pmid">20519386</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>TE</given-names></name><name><surname>Oko</surname><given-names>L</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>Whitmore</surname><given-names>AC</given-names></name><name><surname>Lotstein</surname><given-names>AR</given-names></name><name><surname>Gunn</surname><given-names>BM</given-names></name><etal/></person-group>. <article-title>A mouse model of chikungunya virus&#x02013;induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence</article-title>. <source>Am J Pathol</source>. (<year>2011</year>) <volume>178</volume>:<fpage>32</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2010.11.018</pub-id><?supplied-pmid 21224040?><pub-id pub-id-type="pmid">21224040</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>TH</given-names></name><name><surname>Lum</surname><given-names>M</given-names></name><name><surname>Claser</surname><given-names>C</given-names></name><name><surname>Lulla</surname><given-names>V</given-names></name><name><surname>Lulla</surname><given-names>A</given-names></name><name><surname>Merits</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>A pathogenic role for CD4+ T cells during chikungunya virus infection in mice</article-title>. <source>J Immunol</source>. (<year>2013</year>) <volume>190</volume>:<fpage>259</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1202177</pub-id><?supplied-pmid 23209328?><pub-id pub-id-type="pmid">23209328</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panning</surname><given-names>M</given-names></name><name><surname>Grywna</surname><given-names>K</given-names></name><name><surname>Van Esbroeck</surname><given-names>M</given-names></name><name><surname>Emmerich</surname><given-names>P</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name></person-group>. <article-title>Chikungunya fever in travelers returning to Europe from the Indian Ocean region, (2006)</article-title>. <source>Emerg Infect Dis</source>. (<year>2008</year>) <volume>14</volume>:<fpage>416</fpage>. <pub-id pub-id-type="doi">10.3201/eid1403.070906</pub-id><?supplied-pmid 18325256?><pub-id pub-id-type="pmid">18325256</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Nayak</surname><given-names>K</given-names></name><name><surname>Tanwar</surname><given-names>N</given-names></name><name><surname>Gaind</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>B</given-names></name><name><surname>Shastri</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Clinical, serological, and virological analysis of 572 chikungunya patients from 2010 to 2013 in India</article-title>. <source>Clin Infect Dis</source>. (<year>2017</year>) <volume>65</volume>:<fpage>133</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cix283</pub-id><?supplied-pmid 28379375?><pub-id pub-id-type="pmid">28379375</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kam</surname><given-names>YW</given-names></name><name><surname>Lum</surname><given-names>FM</given-names></name><name><surname>Teo</surname><given-names>TH</given-names></name><name><surname>Lee</surname><given-names>WW</given-names></name><name><surname>Simarmata</surname><given-names>D</given-names></name><name><surname>Harjanto</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Early neutralizing IgG response to chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein</article-title>. <source>EMBO Mol Med</source>. (<year>2012</year>) <volume>4</volume>:<fpage>330</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201200213</pub-id><?supplied-pmid 22389221?><pub-id pub-id-type="pmid">22389221</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kam</surname><given-names>W</given-names></name><name><surname>Simarmata</surname><given-names>D</given-names></name><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Her</surname><given-names>Z</given-names></name><name><surname>Teng</surname><given-names>S</given-names></name><name><surname>Ong</surname><given-names>EK</given-names></name><etal/></person-group>. <article-title>Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection</article-title>. <source>J Infect Dis</source>. (<year>2012</year>) <volume>205</volume>:<fpage>1147</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jis033</pub-id><?supplied-pmid 22389226?><pub-id pub-id-type="pmid">22389226</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum</surname><given-names>M</given-names></name><name><surname>Teo</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>WW</given-names></name><name><surname>Kam</surname><given-names>W</given-names></name><name><surname>R&#x000e9;nia</surname><given-names>L</given-names></name><name><surname>Ng</surname><given-names>LF</given-names></name></person-group>. <article-title>An essential role of antibodies in the control of chikungunya virus infection</article-title>. <source>J Immunol</source>. (<year>2013</year>) <volume>190</volume>:<fpage>6295</fpage>&#x02013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1300304</pub-id><?supplied-pmid 23670192?><pub-id pub-id-type="pmid">23670192</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JM</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name></person-group>. <article-title>Immune-mediated protection and pathogenesis of chikungunya virus</article-title>. <source>J Immunol</source>. (<year>2016</year>) <volume>197</volume>:<fpage>4210</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1601426</pub-id><?supplied-pmid 27864552?><pub-id pub-id-type="pmid">27864552</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolint</surname><given-names>P</given-names></name><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>Koup</surname><given-names>RA</given-names></name><name><surname>Oxenius</surname><given-names>A</given-names></name></person-group>
<article-title>Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells</article-title>. <source>J Exp Med</source>. (<year>2004</year>) <volume>199</volume>:<fpage>925</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20031799</pub-id><pub-id pub-id-type="pmid">15051762</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>NS</given-names></name><name><surname>Gois</surname><given-names>BM</given-names></name><name><surname>Lima</surname><given-names>VS</given-names></name><name><surname>Guerra-Gomes</surname><given-names>IC</given-names></name><name><surname>Araujo</surname><given-names>MG</given-names></name><name><surname>Gomes</surname><given-names>AS</given-names></name><etal/></person-group>. <article-title>Human CD8 T-cell activation in acute and chronic chikungunya infection</article-title>. <source>Immunology</source>. (<year>2018</year>) <volume>155</volume>:<fpage>499</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12992</pub-id><?supplied-pmid 30099739?><pub-id pub-id-type="pmid">30099739</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couderc</surname><given-names>T</given-names></name><name><surname>Khandoudi</surname><given-names>N</given-names></name><name><surname>Grandadam</surname><given-names>M</given-names></name><name><surname>Visse</surname><given-names>C</given-names></name><name><surname>Gangneux</surname><given-names>N</given-names></name><name><surname>Bagot</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Prophylaxis and therapy for chikungunya virus infection</article-title>. <source>J Infect Dis</source>. (<year>2009</year>) <volume>200</volume>:<fpage>516</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1086/600381</pub-id><?supplied-pmid 19572805?><pub-id pub-id-type="pmid">19572805</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tandale</surname><given-names>BV</given-names></name><name><surname>Sathe</surname><given-names>PS</given-names></name><name><surname>Arankalle</surname><given-names>VA</given-names></name><name><surname>Wadia</surname><given-names>RS</given-names></name><name><surname>Kulkarni</surname><given-names>R</given-names></name><name><surname>Shah</surname><given-names>SV</given-names></name><etal/></person-group>. <article-title>Systemic involvements and fatalities during chikungunya epidemic in India, (2006)</article-title>. <source>J Clin Virol</source>. (<year>2009</year>) <volume>46</volume>:<fpage>145</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2009.06.027</pub-id><?supplied-pmid 19640780?><pub-id pub-id-type="pmid">19640780</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>BW</given-names></name><name><surname>Russell</surname><given-names>BJ</given-names></name><name><surname>Goodman</surname><given-names>CH</given-names></name></person-group>. <article-title>Laboratory diagnosis of chikungunya virus infections and commercial sources for diagnostic assays</article-title>. <source>J Infect Dis</source>. (<year>2016</year>) <volume>214</volume>:<fpage>S471</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiw274</pub-id><?supplied-pmid 27920176?><pub-id pub-id-type="pmid">27920176</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Narayanan</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Shrinet</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>P</given-names></name><name><surname>Chaturvedi</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Establishment and comparison of pathogenicity and related neurotropism in two age groups of immune competent mice, C57BL/6J using an Indian isolate of chikungunya virus (CHIKV)</article-title>. <source>Viruses.</source> (<year>2019</year>) <volume>11</volume>:<fpage>578</fpage>. <pub-id pub-id-type="doi">10.3390/v11060578</pub-id><?supplied-pmid 31242674?><pub-id pub-id-type="pmid">31242674</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierro</surname><given-names>A</given-names></name><name><surname>Rossini</surname><given-names>G</given-names></name><name><surname>Gaibani</surname><given-names>P</given-names></name><name><surname>Finarelli</surname><given-names>AC</given-names></name><name><surname>Moro</surname><given-names>ML</given-names></name><name><surname>Landini</surname><given-names>MP</given-names></name><etal/></person-group>. <article-title>Persistence of anti&#x02013;chikungunya virus&#x02013;specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy</article-title>. <source>N Microbes N Infect</source>. (<year>2015</year>) <volume>7</volume>:<fpage>23</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmni.2015.04.002</pub-id><?supplied-pmid 26106482?><pub-id pub-id-type="pmid">26106482</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malvy</surname><given-names>D</given-names></name><name><surname>Ezzedine</surname><given-names>K</given-names></name><name><surname>Mamani-Matsuda</surname><given-names>M</given-names></name><name><surname>Autran</surname><given-names>B</given-names></name><name><surname>Tolou</surname><given-names>H</given-names></name><name><surname>Receveur</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies</article-title>. <source>BMC Infect Dis</source>. (<year>2009</year>) <volume>9</volume>:<fpage>200</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-9-200</pub-id><?supplied-pmid 20003320?><pub-id pub-id-type="pmid">20003320</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Takeshita</surname><given-names>N</given-names></name><name><surname>Ujiie</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kanagawa</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine</article-title>. <source>J Infect Chemother</source>. (<year>2011</year>) <volume>17</volume>:<fpage>419</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1007/s10156-010-0124-y</pub-id><?supplied-pmid 20862507?><pub-id pub-id-type="pmid">20862507</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilte</surname><given-names>C</given-names></name><name><surname>Staikowsky</surname><given-names>F</given-names></name><name><surname>Couderc</surname><given-names>T</given-names></name><name><surname>Madec</surname><given-names>Y</given-names></name><name><surname>Carpentier</surname><given-names>F</given-names></name><name><surname>Kassab</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study</article-title>. <source>PLoS Negl Trop Dis</source>. (<year>2013</year>) <volume>7</volume>:<fpage>e2137</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0002137</pub-id><?supplied-pmid 23556021?><pub-id pub-id-type="pmid">23556021</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Fong</surname><given-names>RH</given-names></name><name><surname>Austin</surname><given-names>SK</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Klose</surname><given-names>T</given-names></name><name><surname>Fokine</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2015</year>) <volume>112</volume>:<fpage>13898</fpage>&#x02013;<lpage>903</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1515558112</pub-id><?supplied-pmid 26504196?><pub-id pub-id-type="pmid">26504196</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JM</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Edeling</surname><given-names>MA</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>van</surname><given-names>Duijl-Richter MK</given-names></name><name><surname>Fong</surname><given-names>RH</given-names></name><etal/></person-group>. <article-title>Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress</article-title>. <source>Cell</source>. (<year>2015</year>) <volume>163</volume>:<fpage>1095</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.10.050</pub-id><?supplied-pmid 26553503?><pub-id pub-id-type="pmid">26553503</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SA</given-names></name><name><surname>Silva</surname><given-names>LA</given-names></name><name><surname>Fox</surname><given-names>JM</given-names></name><name><surname>Flyak</surname><given-names>AI</given-names></name><name><surname>Kose</surname><given-names>N</given-names></name><name><surname>Sapparapu</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Isolation and characterization of broad and ultrapotent human monoclonal antibodies with therapeutic activity against chikungunya virus</article-title>. <source>Cell Host Microbe</source>. (<year>2015</year>) <volume>18</volume>:<fpage>86</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.06.009</pub-id><?supplied-pmid 26159721?><pub-id pub-id-type="pmid">26159721</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawman</surname><given-names>DW</given-names></name><name><surname>Fox</surname><given-names>JM</given-names></name><name><surname>Ashbrook</surname><given-names>AW</given-names></name><name><surname>May</surname><given-names>NA</given-names></name><name><surname>Schroeder</surname><given-names>KM</given-names></name><name><surname>Torres</surname><given-names>RM</given-names></name><etal/></person-group>. <article-title>Pathogenic chikungunya virus evades B cell responses to establish persistence</article-title>. <source>Cell Rep</source>. (<year>2016</year>) <volume>16</volume>:<fpage>1326</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.06.076</pub-id><?supplied-pmid 27452455?><pub-id pub-id-type="pmid">27452455</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broeckel</surname><given-names>R</given-names></name><name><surname>Fox</surname><given-names>JM</given-names></name><name><surname>Haese</surname><given-names>N</given-names></name><name><surname>Kreklywich</surname><given-names>CN</given-names></name><name><surname>Sukulpovi-Petty</surname><given-names>S</given-names></name><name><surname>Legasse</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques</article-title>. <source>PLoS Neglect Trop Dis</source>. (<year>2017</year>) <volume>11</volume>:<fpage>e0005637</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0005637</pub-id><?supplied-pmid 28628616?><pub-id pub-id-type="pmid">28628616</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>P</given-names></name><name><surname>Dowd</surname><given-names>KA</given-names></name><name><surname>Brien</surname><given-names>JD</given-names></name><name><surname>Edeling</surname><given-names>MA</given-names></name><name><surname>Gorlatov</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Development of a highly protective combination monoclonal antibody therapy against chikungunya virus</article-title>. <source>PLoS Pathog.</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003312</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003312</pub-id><?supplied-pmid 23637602?><pub-id pub-id-type="pmid">23637602</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fric</surname><given-names>J</given-names></name><name><surname>Bertin-Maghit</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>CI</given-names></name><name><surname>Nardin</surname><given-names>A</given-names></name><name><surname>Warter</surname><given-names>L</given-names></name></person-group>. <article-title>Use of human monoclonal antibodies to treat chikungunya virus infection</article-title>. <source>J Infect Dis</source>. (<year>2013</year>) <volume>207</volume>:<fpage>319</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jis674</pub-id><?supplied-pmid 23125446?><pub-id pub-id-type="pmid">23125446</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawman</surname><given-names>DW</given-names></name><name><surname>Stoermer</surname><given-names>KA</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>Pal</surname><given-names>P</given-names></name><name><surname>Oko</surname><given-names>L</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><etal/></person-group>. <article-title>Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response</article-title>. <source>J Virol</source>. (<year>2013</year>) <volume>87</volume>:<fpage>13878</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02666-13</pub-id><?supplied-pmid 24131709?><pub-id pub-id-type="pmid">24131709</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Bruhns</surname><given-names>P</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name><name><surname>Hammad</surname><given-names>H</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name></person-group>. <article-title>The function of Fcgamma receptors in dendritic cells and macrophages</article-title>. <source>Nat Rev Immunol</source>. (<year>2014</year>) <volume>14</volume>:<fpage>94</fpage>&#x02013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1038/nri3582</pub-id><?supplied-pmid 24445665?><pub-id pub-id-type="pmid">24445665</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubes</surname><given-names>P</given-names></name><name><surname>Jenne</surname><given-names>C</given-names></name></person-group>. <article-title>Immune responses in the liver</article-title>. <source>Annu Rev Immunol</source>. (<year>2018</year>) <volume>36</volume>:<fpage>247</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-051116-052415</pub-id><?supplied-pmid 29328785?><pub-id pub-id-type="pmid">29328785</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Lookeren Campagne</surname><given-names>M</given-names></name><name><surname>Wiesmann</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name></person-group>. <article-title>Macrophage complement receptors and pathogen clearance</article-title>. <source>Cell Microbiol</source>. (<year>2007</year>) <volume>9</volume>:<fpage>2095</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00981.x</pub-id><?supplied-pmid 17590164?><pub-id pub-id-type="pmid">17590164</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpentier</surname><given-names>KS</given-names></name><name><surname>Davenport</surname><given-names>BJ</given-names></name><name><surname>Haist</surname><given-names>KC</given-names></name><name><surname>McCarthy</surname><given-names>MK</given-names></name><name><surname>May</surname><given-names>NA</given-names></name><name><surname>Robison</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses</article-title>. <source>Elife.</source> (<year>2019</year>) <volume>8</volume>:<fpage>e49163</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.49163</pub-id><?supplied-pmid 31596239?><pub-id pub-id-type="pmid">31596239</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>D</given-names></name><name><surname>Roes</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>R</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group>. <article-title>A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene</article-title>. <source>Nature</source>. (<year>1991</year>) <volume>350</volume>:<fpage>423</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/350423a0</pub-id><?supplied-pmid 1901381?><pub-id pub-id-type="pmid">1901381</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessels</surname><given-names>MR</given-names></name><name><surname>Butko</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Warren</surname><given-names>HB</given-names></name><name><surname>Lage</surname><given-names>AL</given-names></name><name><surname>Carroll</surname><given-names>MC</given-names></name></person-group>. <article-title>Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1995</year>) <volume>92</volume>:<fpage>11490</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.25.11490</pub-id><?supplied-pmid 8524789?><pub-id pub-id-type="pmid">8524789</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canton</surname><given-names>J</given-names></name><name><surname>Neculai</surname><given-names>D</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group>. <article-title>Scavenger receptors in homeostasis and immunity</article-title>. <source>Nat Rev Immunol</source>. (<year>2013</year>) <volume>13</volume>:<fpage>621</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nri3515</pub-id><?supplied-pmid 23928573?><pub-id pub-id-type="pmid">23928573</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>. <article-title>The role of scavenger receptors in pathogen recognition and innate immunity</article-title>. <source>Immunobiology</source>. (<year>2004</year>) <volume>209</volume>:<fpage>39</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2004.02.004</pub-id><?supplied-pmid 15481139?><pub-id pub-id-type="pmid">15481139</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Pro-resolving lipid mediators are leads for resolution physiology</article-title>. <source>Nature</source>. (<year>2014</year>) <volume>510</volume>:<fpage>92</fpage>. <pub-id pub-id-type="doi">10.1038/nature13479</pub-id><?supplied-pmid 24899309?><pub-id pub-id-type="pmid">24899309</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perretti</surname><given-names>M</given-names></name><name><surname>D'acquisto</surname><given-names>F</given-names></name></person-group>. <article-title>Annexin A1 and glucocorticoids as effectors of the resolution of inflammation</article-title>. <source>Nat Rev Immunol</source>. (<year>2009</year>) <volume>9</volume>:<fpage>62</fpage>. <pub-id pub-id-type="doi">10.1038/nri2470</pub-id><?supplied-pmid 19104500?><pub-id pub-id-type="pmid">19104500</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Ianaro</surname><given-names>A</given-names></name><name><surname>Flannigan</surname><given-names>KL</given-names></name><name><surname>Cirino</surname><given-names>G</given-names></name></person-group>. <article-title>Gaseous mediators in resolution of inflammation</article-title>. <source>Sem Immunol.</source> (<year>2015</year>). <fpage>227</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2015.05.004</pub-id><?supplied-pmid 26095908?><pub-id pub-id-type="pmid">26095908</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirakaj</surname><given-names>V</given-names></name><name><surname>Dalli</surname><given-names>J</given-names></name><name><surname>Granja</surname><given-names>T</given-names></name><name><surname>Rosenberger</surname><given-names>P</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Vagus nerve controls resolution and pro-resolving mediators of inflammation</article-title>. <source>J Exp Med</source>. (<year>2014</year>) <volume>211</volume>:<fpage>1037</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20132103</pub-id><?supplied-pmid 24863066?><pub-id pub-id-type="pmid">24863066</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlov</surname><given-names>VA</given-names></name><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group>. <article-title>The vagus nerve and the inflammatory reflex&#x02014;linking immunity and metabolism</article-title>. <source>Nat Rev Endocrinol</source>. (<year>2012</year>) <volume>8</volume>:<fpage>743</fpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2012.189</pub-id><?supplied-pmid 23169440?><pub-id pub-id-type="pmid">23169440</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puttamallesh</surname><given-names>VN</given-names></name><name><surname>Sreenivasamurthy</surname><given-names>SK</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>Harsha</surname><given-names>HC</given-names></name><name><surname>Ganjiwale</surname><given-names>A</given-names></name><name><surname>Broor</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host response</article-title>. <source>Clin Proteomics</source>. (<year>2013</year>) <volume>10</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/1559-0275-10-14</pub-id><?supplied-pmid 24124767?><pub-id pub-id-type="pmid">24124767</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>MA</given-names></name><name><surname>Sousa</surname><given-names>LP</given-names></name><name><surname>Pinho</surname><given-names>V</given-names></name><name><surname>Perretti</surname><given-names>M</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name></person-group>. <article-title>Resolution of inflammation: what controls its onset?</article-title>
<source>Front Immunol</source>. (<year>2016</year>) <volume>7</volume>:<fpage>160</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00160</pub-id><?supplied-pmid 27199985?><pub-id pub-id-type="pmid">27199985</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JA</given-names></name><name><surname>Prow</surname><given-names>NA</given-names></name><name><surname>Schroder</surname><given-names>WA</given-names></name><name><surname>Ellis</surname><given-names>JJ</given-names></name><name><surname>Cumming</surname><given-names>HE</given-names></name><name><surname>Gearing</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation</article-title>. <source>PLoS Pathog</source>. (<year>2017</year>) <volume>13</volume>:<fpage>e1006155</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006155</pub-id><?supplied-pmid 28207896?><pub-id pub-id-type="pmid">28207896</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Zen</surname><given-names>K</given-names></name></person-group>. <article-title>Molecular mechanisms that influence the macrophage M1&#x02013;M2 polarization balance</article-title>. <source>Front Immunol</source>. (<year>2014</year>) <volume>5</volume>:<fpage>614</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00614</pub-id><?supplied-pmid 25506346?><pub-id pub-id-type="pmid">25506346</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imtiyaz</surname><given-names>HZ</given-names></name><name><surname>Williams</surname><given-names>EP</given-names></name><name><surname>Hickey</surname><given-names>MM</given-names></name><name><surname>Patel</surname><given-names>SA</given-names></name><name><surname>Durham</surname><given-names>AC</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Hypoxia-inducible factor 2&#x003b1; regulates macrophage function in mouse models of acute and tumor inflammation</article-title>. <source>J Clin Invest.</source> (<year>2010</year>) <volume>120</volume>:<fpage>2699</fpage>&#x02013;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1172/JCI39506</pub-id><?supplied-pmid 20644254?><pub-id pub-id-type="pmid">20644254</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoermer</surname><given-names>KA</given-names></name><name><surname>Burrack</surname><given-names>A</given-names></name><name><surname>Oko</surname><given-names>L</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>Borst</surname><given-names>LB</given-names></name><name><surname>Gill</surname><given-names>RG</given-names></name><etal/></person-group>. <article-title>Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus</article-title>. <source>J Immunol</source>. (<year>2012</year>) <volume>189</volume>:<fpage>4047</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1201240</pub-id><?supplied-pmid 22972923?><pub-id pub-id-type="pmid">22972923</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>MA</given-names></name></person-group>. <article-title>microRNAs and the immune response</article-title>. <source>Trends Immunol.</source> (<year>2008</year>) <volume>29</volume>:<fpage>343</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2008.04.004</pub-id><?supplied-pmid 18515182?><pub-id pub-id-type="pmid">18515182</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname><given-names>O</given-names></name></person-group>. <article-title>Common logic of transcription factor and microRNA action</article-title>. <source>Trends Biochem Sci.</source> (<year>2004</year>) <volume>29</volume>:<fpage>462</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2004.07.001</pub-id><?supplied-pmid 15337119?><pub-id pub-id-type="pmid">15337119</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>Z</given-names></name><name><surname>Mallick</surname><given-names>B</given-names></name><name><surname>Chakrabarti</surname><given-names>J</given-names></name></person-group>. <article-title>Cellular versus viral microRNAs in host&#x02013;virus interaction</article-title>. <source>Nucleic Acids Res</source>. (<year>2008</year>) <volume>37</volume>:<fpage>1035</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn1004</pub-id><?supplied-pmid 19095692?><pub-id pub-id-type="pmid">19095692</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottwein</surname><given-names>E</given-names></name><name><surname>Cullen</surname><given-names>BR</given-names></name></person-group>. <article-title>Viral and cellular microRNAs as determinants of viral pathogenesis and immunity</article-title>. <source>Cell Host Microbe</source>. (<year>2008</year>) <volume>3</volume>:<fpage>375</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2008.05.002</pub-id><?supplied-pmid 18541214?><pub-id pub-id-type="pmid">18541214</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatzikyriakidou</surname><given-names>A</given-names></name><name><surname>Voulgari</surname><given-names>PV</given-names></name><name><surname>Georgiou</surname><given-names>I</given-names></name><name><surname>Drosos</surname><given-names>AA</given-names></name></person-group>. <article-title>miRNAs and related polymorphisms in rheumatoid arthritis susceptibility</article-title>. <source>Autoimmun Rev</source>. (<year>2012</year>) <volume>11</volume>:<fpage>636</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2011.11.004</pub-id><?supplied-pmid 22100329?><pub-id pub-id-type="pmid">22100329</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurowska-Stolarska</surname><given-names>M</given-names></name><name><surname>Alivernini</surname><given-names>S</given-names></name><name><surname>Ballantine</surname><given-names>LE</given-names></name><name><surname>Asquith</surname><given-names>DL</given-names></name><name><surname>Millar</surname><given-names>NL</given-names></name><name><surname>Gilchrist</surname><given-names>DS</given-names></name><etal/></person-group>. <article-title>MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2011</year>) <volume>108</volume>:<fpage>11193</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1019536108</pub-id><?supplied-pmid 21690378?><pub-id pub-id-type="pmid">21690378</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parashar</surname><given-names>D</given-names></name><name><surname>Paingankar</surname><given-names>MS</given-names></name><name><surname>More</surname><given-names>A</given-names></name><name><surname>Patil</surname><given-names>P</given-names></name><name><surname>Amdekar</surname><given-names>S</given-names></name></person-group>. <article-title>Altered microRNA expression signature in chikungunya-infected mammalian fibroblast cells</article-title>. <source>Virus Genes</source>. (<year>2018</year>) <volume>54</volume>:<fpage>502</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1007/s11262-018-1578-8</pub-id><?supplied-pmid 29872954?><pub-id pub-id-type="pmid">29872954</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>T</given-names></name><name><surname>Tandon</surname><given-names>B</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Chameettachal</surname><given-names>S</given-names></name><name><surname>Ray</surname><given-names>P</given-names></name><name><surname>Ray</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Combined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells</article-title>. <source>PLoS ONE</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e79886</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0079886</pub-id><?supplied-pmid 24278205?><pub-id pub-id-type="pmid">24278205</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvamani</surname><given-names>SP</given-names></name><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name></person-group>. <article-title>Chikungunya virus exploits miR-146a to regulate NF-&#x003ba;B pathway in human synovial fibroblasts</article-title>. <source>PLoS ONE</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e103624</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103624</pub-id><?supplied-pmid 25083878?><pub-id pub-id-type="pmid">25083878</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JM</given-names></name><name><surname>Clement</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Lukiw</surname><given-names>WJ</given-names></name></person-group>. <article-title>Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses</article-title>. <source>Front Microbiol.</source> (<year>2015</year>) <volume>6</volume>:<fpage>43</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.00043</pub-id><?supplied-pmid 25691883?><pub-id pub-id-type="pmid">25691883</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5</article-title>. <source>EBio Med</source>. (<year>2016</year>) <volume>14</volume>:<fpage>83</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2016.10.041</pub-id><?supplied-pmid 27825654?><pub-id pub-id-type="pmid">27825654</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtale</surname><given-names>G</given-names></name><name><surname>Rubino</surname><given-names>M</given-names></name><name><surname>Locati</surname><given-names>M</given-names></name></person-group>. <article-title>MicroRNAs as molecular switches in macrophage activation</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>799</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00799</pub-id><?supplied-pmid 31057539?><pub-id pub-id-type="pmid">31057539</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name></person-group>. <article-title>Transcriptional regulation of macrophages polarization by MicroRNAs</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>1175</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01175</pub-id><?supplied-pmid 29892301?><pub-id pub-id-type="pmid">29892301</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name></person-group>. <article-title>MiR-210 inhibits NF-&#x003ba;B signaling pathway by targeting DR6 in osteoarthritis</article-title>. <source>Sci Rep</source>. (<year>2015</year>) <volume>5</volume>:<fpage>12775</fpage>. <pub-id pub-id-type="doi">10.1038/srep12775</pub-id><?supplied-pmid 26244598?><pub-id pub-id-type="pmid">26244598</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name></person-group>. <article-title>microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-kappaB1 in murine macrophages</article-title>. <source>FEBS Lett</source>. (<year>2012</year>) <volume>586</volume>:<fpage>1201</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2012.03.011</pub-id><?supplied-pmid 22575656?><pub-id pub-id-type="pmid">22575656</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Paul</surname><given-names>WE</given-names></name></person-group>. <article-title>Heterogeneity and plasticity of T helper cells</article-title>. <source>Cell Res</source>. (<year>2010</year>) <volume>20</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1038/cr.2009.138</pub-id><?supplied-pmid 20010916?><pub-id pub-id-type="pmid">20010916</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldhoen</surname><given-names>M</given-names></name><name><surname>Hocking</surname><given-names>RJ</given-names></name><name><surname>Atkins</surname><given-names>CJ</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name><name><surname>Stockinger</surname><given-names>B</given-names></name></person-group>. <article-title>TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells</article-title>. <source>Immunity</source>. (<year>2006</year>) <volume>24</volume>:<fpage>179</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2006.01.001</pub-id><?supplied-pmid 16473830?><pub-id pub-id-type="pmid">16473830</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangan</surname><given-names>PR</given-names></name><name><surname>Harrington</surname><given-names>LE</given-names></name><name><surname>O'Quinn</surname><given-names>DB</given-names></name><name><surname>Helms</surname><given-names>WS</given-names></name><name><surname>Bullard</surname><given-names>DC</given-names></name><name><surname>Elson</surname><given-names>CO</given-names></name><etal/></person-group>. <article-title>Transforming growth factor-beta induces development of the T(H)17 lineage</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>441</volume>:<fpage>231</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nature04754</pub-id><?supplied-pmid 16648837?><pub-id pub-id-type="pmid">16648837</pub-id></mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettelli</surname><given-names>E</given-names></name><name><surname>Carrier</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Korn</surname><given-names>T</given-names></name><name><surname>Strom</surname><given-names>TB</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>441</volume>:<fpage>235</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nature04753</pub-id><?supplied-pmid 16648838?><pub-id pub-id-type="pmid">16648838</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>GR</given-names></name></person-group>. <article-title>The balance of Th17 versus Treg cells in autoimmunity</article-title>. <source>Int J Mol Sci.</source> (<year>2018</year>) <volume>19</volume>:<fpage>730</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19030730</pub-id><?supplied-pmid 29510522?><pub-id pub-id-type="pmid">29510522</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>WW</given-names></name><name><surname>Teo</surname><given-names>TH</given-names></name><name><surname>Her</surname><given-names>Z</given-names></name><name><surname>Lum</surname><given-names>FM</given-names></name><name><surname>Kam</surname><given-names>YW</given-names></name><name><surname>Haase</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice</article-title>. <source>J Virol</source>. (<year>2015</year>) <volume>89</volume>:<fpage>7893</fpage>&#x02013;<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00998-15</pub-id><?supplied-pmid 25995249?><pub-id pub-id-type="pmid">25995249</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaffen</surname><given-names>SL</given-names></name></person-group>. <article-title>Structure and signalling in the IL-17 receptor family</article-title>. <source>Nat Rev Immunol</source>. (<year>2009</year>) <volume>9</volume>:<fpage>556</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1038/nri2586</pub-id><?supplied-pmid 19575028?><pub-id pub-id-type="pmid">19575028</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenders</surname><given-names>MI</given-names></name><name><surname>Marijnissen</surname><given-names>RJ</given-names></name><name><surname>Devesa</surname><given-names>I</given-names></name><name><surname>Lubberts</surname><given-names>E</given-names></name><name><surname>Joosten</surname><given-names>LA</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1beta, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis</article-title>. <source>Arthritis Rheum</source>. (<year>2011</year>) <volume>63</volume>:<fpage>2329</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1002/art.30418</pub-id><?supplied-pmid 21520013?><pub-id pub-id-type="pmid">21520013</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaaitanya</surname><given-names>IK</given-names></name><name><surname>Muruganandam</surname><given-names>N</given-names></name><name><surname>Sundaram</surname><given-names>SG</given-names></name><name><surname>Kawalekar</surname><given-names>O</given-names></name><name><surname>Sugunan</surname><given-names>AP</given-names></name><name><surname>Manimunda</surname><given-names>SP</given-names></name><etal/></person-group>. <article-title>Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection</article-title>. <source>Viral Immunol</source>. (<year>2011</year>) <volume>24</volume>:<fpage>265</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1089/vim.2010.0123</pub-id><?supplied-pmid 21830898?><pub-id pub-id-type="pmid">21830898</pub-id></mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>LF</given-names></name><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>YJ</given-names></name><name><surname>Kwek</surname><given-names>DJ</given-names></name><name><surname>Lim</surname><given-names>PL</given-names></name><name><surname>Dimatatac</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>IL-1beta, IL-6, and RANTES as biomarkers of chikungunya severity</article-title>. <source>PLoS ONE</source>. (<year>2009</year>) <volume>4</volume>:<fpage>e4261</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0004261</pub-id><?supplied-pmid 19156204?><pub-id pub-id-type="pmid">19156204</pub-id></mixed-citation></ref><ref id="B164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohachanakul</surname><given-names>J</given-names></name><name><surname>Phuklia</surname><given-names>W</given-names></name><name><surname>Thannagith</surname><given-names>M</given-names></name><name><surname>Thonsakulprasert</surname><given-names>T</given-names></name><name><surname>Ubol</surname><given-names>S</given-names></name></person-group>. <article-title>High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand</article-title>. <source>Microbiol Immunol</source>. (<year>2012</year>) <volume>56</volume>:<fpage>134</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1348-0421.2011.00417.x</pub-id><?supplied-pmid 22188545?><pub-id pub-id-type="pmid">22188545</pub-id></mixed-citation></ref><ref id="B165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manet</surname><given-names>C</given-names></name><name><surname>Simon-Lori&#x000e8;re</surname><given-names>E</given-names></name><name><surname>Jouvion</surname><given-names>G</given-names></name><name><surname>Hardy</surname><given-names>D</given-names></name><name><surname>Prot</surname><given-names>M</given-names></name><name><surname>Conquet</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Genetic diversity of collaborative cross mice controls viral replication, clinical severity and brain pathology induced by zika virus infection, independently of <italic>Oas1b</italic></article-title>. <source>J Virol.</source> (<year>2019</year>) <volume>94</volume>:<fpage>e01034</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1101/677484</pub-id><?supplied-pmid 31694939?><pub-id pub-id-type="pmid">31694939</pub-id></mixed-citation></ref><ref id="B166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosser</surname><given-names>EC</given-names></name><name><surname>Mauri</surname><given-names>C</given-names></name></person-group>. <article-title>Regulatory B cells: origin, phenotype, and function</article-title>. <source>Immunity</source>. (<year>2015</year>) <volume>42</volume>:<fpage>607</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.04.005</pub-id><?supplied-pmid 25902480?><pub-id pub-id-type="pmid">25902480</pub-id></mixed-citation></ref><ref id="B167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rincon-Arevalo</surname><given-names>H</given-names></name><name><surname>Sanchez-Parra</surname><given-names>CC</given-names></name><name><surname>Castano</surname><given-names>D</given-names></name><name><surname>Yassin</surname><given-names>L</given-names></name><name><surname>Vasquez</surname><given-names>G</given-names></name></person-group>. <article-title>Regulatory B cells and mechanisms</article-title>. <source>Int Rev Immunol</source>. (<year>2016</year>) <volume>35</volume>:<fpage>156</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.3109/08830185.2015.1015719</pub-id><?supplied-pmid 25793964?><pub-id pub-id-type="pmid">25793964</pub-id></mixed-citation></ref><ref id="B168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillatreau</surname><given-names>S</given-names></name><name><surname>Sweenie</surname><given-names>CH</given-names></name><name><surname>McGeachy</surname><given-names>MJ</given-names></name><name><surname>Gray</surname><given-names>D</given-names></name><name><surname>Anderton</surname><given-names>SM</given-names></name></person-group>. <article-title>B cells regulate autoimmunity by provision of IL-10</article-title>. <source>Nat Immunol</source>. (<year>2002</year>) <volume>3</volume>:<fpage>944</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1038/ni833</pub-id><?supplied-pmid 12244307?><pub-id pub-id-type="pmid">12244307</pub-id></mixed-citation></ref><ref id="B169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoder</surname><given-names>A</given-names></name><name><surname>Sarvaria</surname><given-names>A</given-names></name><name><surname>Alsuliman</surname><given-names>A</given-names></name><name><surname>Chew</surname><given-names>C</given-names></name><name><surname>Sekine</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD</article-title>. <source>Blood</source>. (<year>2014</year>) <volume>124</volume>:<fpage>2034</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2014-04-571125</pub-id><?supplied-pmid 25051962?><pub-id pub-id-type="pmid">25051962</pub-id></mixed-citation></ref><ref id="B170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauri</surname><given-names>C</given-names></name><name><surname>Menon</surname><given-names>M</given-names></name></person-group>. <article-title>The expanding family of regulatory B cells</article-title>. <source>Int Immunol</source>. (<year>2015</year>) <volume>27</volume>:<fpage>479</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxv038</pub-id><?supplied-pmid 26071023?><pub-id pub-id-type="pmid">26071023</pub-id></mixed-citation></ref><ref id="B171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>CH</given-names></name><name><surname>Chiang</surname><given-names>BL</given-names></name></person-group>. <article-title>Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells</article-title>. <source>J Biomed Sci</source>. (<year>2017</year>) <volume>24</volume>:<fpage>86</fpage>. <pub-id pub-id-type="doi">10.1186/s12929-017-0391-3</pub-id><?supplied-pmid 29151021?><pub-id pub-id-type="pmid">29151021</pub-id></mixed-citation></ref><ref id="B172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>K</given-names></name><name><surname>Simpson</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Cowan</surname><given-names>G</given-names></name><name><surname>Gray</surname><given-names>D</given-names></name><name><surname>Gray</surname><given-names>M</given-names></name></person-group>. <article-title>Immune tolerance to apoptotic self is mediated primarily by regulatory B1a cells</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<fpage>1952</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01952</pub-id><?supplied-pmid 29403471?><pub-id pub-id-type="pmid">29403471</pub-id></mixed-citation></ref><ref id="B173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>RS</given-names></name><name><surname>Filer</surname><given-names>A</given-names></name><name><surname>Cooper</surname><given-names>MS</given-names></name><name><surname>Parsonage</surname><given-names>G</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Hardie</surname><given-names>DL</given-names></name><etal/></person-group>. <article-title>Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation</article-title>. <source>Arthritis Res Ther</source>. (<year>2006</year>) <volume>8</volume>:<fpage>R108</fpage>. <pub-id pub-id-type="doi">10.1186/ar1993</pub-id><?supplied-pmid 16846535?><pub-id pub-id-type="pmid">16846535</pub-id></mixed-citation></ref><ref id="B174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity</article-title>. <source>Clin Exp Med</source>. (<year>2015</year>) <volume>15</volume>:<fpage>285</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s10238-014-0310-9</pub-id><?supplied-pmid 25245953?><pub-id pub-id-type="pmid">25245953</pub-id></mixed-citation></ref><ref id="B175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzetti</surname><given-names>R</given-names></name><name><surname>Janowska</surname><given-names>I</given-names></name><name><surname>Smulski</surname><given-names>CR</given-names></name><name><surname>Frede</surname><given-names>N</given-names></name><name><surname>Henneberger</surname><given-names>N</given-names></name><name><surname>Walter</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells</article-title>. <source>J Autoimmun.</source> (<year>2019</year>) <volume>101</volume>:<fpage>145</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2019.04.016</pub-id><?supplied-pmid 31054942?><pub-id pub-id-type="pmid">31054942</pub-id></mixed-citation></ref><ref id="B176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sissoko</surname><given-names>D</given-names></name><name><surname>Malvy</surname><given-names>D</given-names></name><name><surname>Ezzedine</surname><given-names>K</given-names></name><name><surname>Renault</surname><given-names>P</given-names></name><name><surname>Moscetti</surname><given-names>F</given-names></name><name><surname>Ledrans</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period</article-title>. <source>PLoS Negl Trop Dis</source>. (<year>2009</year>) <volume>3</volume>:<fpage>e389</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0000389</pub-id><?supplied-pmid 19274071?><pub-id pub-id-type="pmid">19274071</pub-id></mixed-citation></ref><ref id="B177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>A</given-names></name><name><surname>Anuradha</surname><given-names>V</given-names></name><name><surname>Ghorpade</surname><given-names>R</given-names></name><name><surname>Saluja</surname><given-names>M</given-names></name></person-group>. <article-title>Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study</article-title>. <source>Epidemiol Infect</source>. (<year>2012</year>) <volume>140</volume>:<fpage>842</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268811001300</pub-id><?supplied-pmid 21767452?><pub-id pub-id-type="pmid">21767452</pub-id></mixed-citation></ref><ref id="B178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waymouth</surname><given-names>HE</given-names></name><name><surname>Zoutman</surname><given-names>DE</given-names></name><name><surname>Towheed</surname><given-names>TE</given-names></name></person-group>. <article-title>Chikungunya-related arthritis: case report and review of the literature</article-title>. <source>Semin Arthritis Rheum</source>. (<year>2013</year>) <volume>43</volume>:<fpage>273</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.semarthrit.2013.03.003</pub-id><?supplied-pmid 23608542?><pub-id pub-id-type="pmid">23608542</pub-id></mixed-citation></ref><ref id="B179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anfasa</surname><given-names>F</given-names></name><name><surname>Provacia</surname><given-names>L</given-names></name><name><surname>GeurtsvanKessel</surname><given-names>C</given-names></name><name><surname>Wever</surname><given-names>R</given-names></name><name><surname>Gerstenbluth</surname><given-names>I</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><etal/></person-group>. <article-title>Hyperferritinemia is a potential marker of chronic chikungunya: a retrospective study on the Island of Curacao during the 2014-2015 outbreak</article-title>. <source>J Clin Virol</source>. (<year>2017</year>) <volume>86</volume>:<fpage>31</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2016.11.003</pub-id><?supplied-pmid 27912127?><pub-id pub-id-type="pmid">27912127</pub-id></mixed-citation></ref><ref id="B180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelvin</surname><given-names>AA</given-names></name><name><surname>Banner</surname><given-names>D</given-names></name><name><surname>Silvi</surname><given-names>G</given-names></name><name><surname>Moro</surname><given-names>ML</given-names></name><name><surname>Spataro</surname><given-names>N</given-names></name><name><surname>Gaibani</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity</article-title>. <source>PLoS Negl Trop Dis</source>. (<year>2011</year>) <volume>5</volume>:<fpage>e1279</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0001279</pub-id><?supplied-pmid 21858242?><pub-id pub-id-type="pmid">21858242</pub-id></mixed-citation></ref><ref id="B181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Her</surname><given-names>Z</given-names></name><name><surname>Ong</surname><given-names>EK</given-names></name><name><surname>Chen</surname><given-names>JM</given-names></name><name><surname>Dimatatac</surname><given-names>F</given-names></name><name><surname>Kwek</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor</article-title>. <source>J Infect Dis</source>. (<year>2011</year>) <volume>203</volume>:<fpage>149</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiq042</pub-id><?supplied-pmid 21288813?><pub-id pub-id-type="pmid">21288813</pub-id></mixed-citation></ref><ref id="B182"><label>182.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gualberto Cavalcanti</surname><given-names>N</given-names></name><name><surname>MeloVilar</surname><given-names>K</given-names></name><name><surname>Branco Pinto Duarte</surname><given-names>AL</given-names></name><name><surname>de Jesus Barreto</surname><given-names>M</given-names></name><name><surname>Cristiny Pereira</surname><given-names>M</given-names></name><name><surname>da Rocha Pitta</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>IL-27 in patients with chikungunya fever: a possible chronicity biomarker?</article-title>
<source>Acta Trop</source>. (<year>2019</year>) <volume>196</volume>:<fpage>48</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2019.05.005</pub-id><?supplied-pmid 31075222?><pub-id pub-id-type="pmid">31075222</pub-id></mixed-citation></ref><ref id="B183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AR</given-names></name><name><surname>Locke</surname><given-names>MC</given-names></name><name><surname>Cook</surname><given-names>LE</given-names></name><name><surname>Hiller</surname><given-names>BE</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Hedberg</surname><given-names>ML</given-names></name><etal/></person-group>. <article-title>Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA</article-title>. <source>PLoS Pathog.</source> (<year>2019</year>). <volume>15</volume>:<fpage>e1007993</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007993</pub-id><?supplied-pmid 31465513?><pub-id pub-id-type="pmid">31465513</pub-id></mixed-citation></ref><ref id="B184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danks</surname><given-names>L</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name></person-group>. <article-title>Immunology and bone</article-title>. <source>J Biochem</source>. (<year>2013</year>) <volume>154</volume>:<fpage>29</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvt049</pub-id><?supplied-pmid 23750028?><pub-id pub-id-type="pmid">23750028</pub-id></mixed-citation></ref><ref id="B185"><label>185.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amdekar</surname><given-names>S</given-names></name><name><surname>Parashar</surname><given-names>D</given-names></name><name><surname>Alagarasu</surname><given-names>K</given-names></name></person-group>. <article-title>Chikungunya virus-induced arthritis: role of host and viral factors in the pathogenesis</article-title>. <source>Viral Immunol</source>. (<year>2017</year>) <volume>30</volume>:<fpage>691</fpage>&#x02013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1089/vim.2017.0052</pub-id><?supplied-pmid 28910194?><pub-id pub-id-type="pmid">28910194</pub-id></mixed-citation></ref><ref id="B186"><label>186.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guegan</surname><given-names>JP</given-names></name><name><surname>Legembre</surname><given-names>P</given-names></name></person-group>. <article-title>Nonapoptotic functions of Fas/CD95 in the immune response</article-title>. <source>FEBS J</source>. (<year>2018</year>) <volume>285</volume>:<fpage>809</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14292</pub-id><?supplied-pmid 29032605?><pub-id pub-id-type="pmid">29032605</pub-id></mixed-citation></ref><ref id="B187"><label>187.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noret</surname><given-names>M</given-names></name><name><surname>Herrero</surname><given-names>L</given-names></name><name><surname>Rulli</surname><given-names>N</given-names></name><name><surname>Rolph</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>PN</given-names></name><name><surname>Li</surname><given-names>RW</given-names></name><etal/></person-group>
<article-title>Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts</article-title>. <source>J Infect Dis</source>. (<year>2012</year>) 206:455&#x02013;<volume>7</volume>:<fpage>7</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jis368</pub-id></mixed-citation></ref><ref id="B188"><label>188.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayanagi</surname><given-names>H</given-names></name></person-group>. <article-title>The role of NFAT in osteoclast formation</article-title>. <source>Ann NY Acad Sci.</source> (<year>2007</year>) <volume>1116</volume>:<fpage>227</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1402.071</pub-id><?supplied-pmid 18083930?><pub-id pub-id-type="pmid">18083930</pub-id></mixed-citation></ref><ref id="B189"><label>189.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincenti</surname><given-names>MP</given-names></name><name><surname>Brinckerhoff</surname><given-names>CE</given-names></name></person-group>. <article-title>Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors</article-title>. <source>Arthritis Res</source>. (<year>2002</year>) <volume>4</volume>:<fpage>157</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1186/ar401</pub-id><?supplied-pmid 12010565?><pub-id pub-id-type="pmid">12010565</pub-id></mixed-citation></ref></ref-list></back></article>